Financial Metrics
INCY INCYTE CORPFinancial Statements
Grouped by statementIncome Statement
Metrics: 6Revenue
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 263464000.0 | — | USD | 10-Q | 2017-05-04 |
| Quarterly | 2016-06-30 | 246288000.0 | -6.5% | USD | 10-Q | 2017-08-01 |
| Quarterly | 2016-09-30 | 269469000.0 | +9.4% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | 384082000.0 | +42.5% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 326444000.0 | -15.0% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 381534000.0 | +16.9% | USD | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | 382282000.0 | +0.2% | USD | 10-Q | 2019-04-30 |
| Quarterly | 2018-06-30 | 521516000.0 | +36.4% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 449683000.0 | -13.8% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 497857000.0 | +10.7% | USD | 10-Q | 2020-05-05 |
| Quarterly | 2019-06-30 | 529932000.0 | +6.4% | USD | 10-Q | 2020-08-04 |
| Quarterly | 2019-09-30 | 551581000.0 | +4.1% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 568507000.0 | +3.1% | USD | 10-Q | 2021-05-04 |
| Quarterly | 2020-06-30 | 688043000.0 | +21.0% | USD | 10-Q | 2021-08-03 |
| Quarterly | 2020-09-30 | 620643000.0 | -9.8% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 604718000.0 | -2.6% | USD | 10-Q | 2022-05-03 |
| Quarterly | 2021-06-30 | 705709000.0 | +16.7% | USD | 10-Q | 2022-08-02 |
| Quarterly | 2021-09-30 | 812987000.0 | +15.2% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 733235000.0 | -9.8% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 911397000.0 | +24.3% | USD | 10-Q | 2023-08-01 |
| Quarterly | 2022-09-30 | 823303000.0 | -9.7% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 808673000.0 | -1.8% | USD | 10-Q | 2024-04-30 |
| Quarterly | 2023-06-30 | 954610000.0 | +18.0% | USD | 10-Q | 2024-07-30 |
| Quarterly | 2023-09-30 | 919025000.0 | -3.7% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 880889000.0 | -4.1% | USD | 10-Q | 2025-04-29 |
| Quarterly | 2024-06-30 | 1043759000.0 | +18.5% | USD | 10-Q | 2025-07-29 |
| Quarterly | 2024-09-30 | 1137871000.0 | +9.0% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 1052898000.0 | -7.5% | USD | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 1215529000.0 | +15.4% | USD | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 1365980000.0 | +12.4% | USD | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 1105719000.0 | — | USD | 10-K | 2019-02-14 |
| Annual | 2017-12-31 | 1536216000.0 | +38.9% | USD | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 1881883000.0 | +22.5% | USD | 10-K | 2021-02-09 |
| Annual | 2019-12-31 | 2158759000.0 | +14.7% | USD | 10-K | 2022-02-08 |
| Annual | 2020-12-31 | 2666702000.0 | +23.5% | USD | 10-K | 2023-02-07 |
| Annual | 2021-12-31 | 2986267000.0 | +12.0% | USD | 10-K | 2024-02-13 |
| Annual | 2022-12-31 | 3394635000.0 | +13.7% | USD | 10-K | 2025-02-10 |
| Annual | 2023-12-31 | 3695649000.0 | +8.9% | USD | 10-K | 2026-02-10 |
| Annual | 2024-12-31 | 4241217000.0 | +14.8% | USD | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 5141242000.0 | +21.2% | USD | 10-K | 2026-02-10 |
Gross Profit
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|
Operating Income
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 36039000.0 | — | USD | 10-Q | 2017-05-04 |
| Quarterly | 2016-06-30 | 44589000.0 | +23.7% | USD | 10-Q | 2017-08-01 |
| Quarterly | 2016-09-30 | 22292000.0 | -50.0% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | -133247000.0 | -697.7% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 7259000.0 | +105.4% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 15019000.0 | +106.9% | USD | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | -67110000.0 | -546.8% | USD | 10-Q | 2019-04-30 |
| Quarterly | 2018-06-30 | 83239000.0 | +224.0% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 31119000.0 | -62.6% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 74070000.0 | +138.0% | USD | 10-Q | 2020-05-05 |
| Quarterly | 2019-06-30 | 98612000.0 | +33.1% | USD | 10-Q | 2020-08-04 |
| Quarterly | 2019-09-30 | 134316000.0 | +36.2% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | -664004000.0 | -594.4% | USD | 10-Q | 2021-05-04 |
| Quarterly | 2020-06-30 | 230773000.0 | +134.8% | USD | 10-Q | 2021-08-03 |
| Quarterly | 2020-09-30 | 5326000.0 | -97.7% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 98797000.0 | +1755.0% | USD | 10-Q | 2022-05-03 |
| Quarterly | 2021-06-30 | 140836000.0 | +42.6% | USD | 10-Q | 2022-08-02 |
| Quarterly | 2021-09-30 | 235410000.0 | +67.2% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 116540000.0 | -50.5% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 254431000.0 | +118.3% | USD | 10-Q | 2023-08-01 |
| Quarterly | 2022-09-30 | 138376000.0 | -45.6% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 24770000.0 | -82.1% | USD | 10-Q | 2024-04-30 |
| Quarterly | 2023-06-30 | 193780000.0 | +682.3% | USD | 10-Q | 2024-07-30 |
| Quarterly | 2023-09-30 | 214705000.0 | +10.8% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 91898000.0 | -57.2% | USD | 10-Q | 2025-04-29 |
| Quarterly | 2024-06-30 | -478130000.0 | -620.3% | USD | 10-Q | 2025-07-29 |
| Quarterly | 2024-09-30 | 146085000.0 | +130.6% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 205168000.0 | +40.4% | USD | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 530314000.0 | +158.5% | USD | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 443518000.0 | -16.4% | USD | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 144998000.0 | — | USD | 10-K | 2019-02-14 |
| Annual | 2017-12-31 | -243387000.0 | -267.9% | USD | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 129223000.0 | +153.1% | USD | 10-K | 2021-02-09 |
| Annual | 2019-12-31 | 402006000.0 | +211.1% | USD | 10-K | 2022-02-08 |
| Annual | 2020-12-31 | -263676000.0 | -165.6% | USD | 10-K | 2023-02-07 |
| Annual | 2021-12-31 | 585777000.0 | +322.2% | USD | 10-K | 2024-02-13 |
| Annual | 2022-12-31 | 579440000.0 | -1.1% | USD | 10-K | 2025-02-10 |
| Annual | 2023-12-31 | 620525000.0 | +7.1% | USD | 10-K | 2026-02-10 |
| Annual | 2024-12-31 | 61366000.0 | -90.1% | USD | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 1514859000.0 | +2368.6% | USD | 10-K | 2026-02-10 |
Net Income
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2017-03-31 | -187083000.0 | — | USD | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | -199567000.0 | -6.7% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | -163513000.0 | +18.1% | USD | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | -41140000.0 | +74.8% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2018-06-30 | 52394000.0 | +227.4% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2018-09-30 | 40430000.0 | -22.8% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 102312000.0 | +153.1% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2019-06-30 | 105318000.0 | +2.9% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2019-09-30 | 335901000.0 | +218.9% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | -720642000.0 | -314.5% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2020-06-30 | 290298000.0 | +140.3% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2020-09-30 | -445547000.0 | -253.5% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 53535000.0 | +112.0% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2021-06-30 | 149456000.0 | +179.2% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2021-09-30 | 384730000.0 | +157.4% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 37992000.0 | -90.1% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2022-06-30 | 161432000.0 | +324.9% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2022-09-30 | 312199000.0 | +93.4% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 21703000.0 | -93.0% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2023-06-30 | 203548000.0 | +837.9% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2023-09-30 | 396520000.0 | +94.8% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 169548000.0 | -57.2% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2024-06-30 | -444601000.0 | -362.2% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2024-09-30 | -168597000.0 | +62.1% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 158203000.0 | +193.8% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2025-06-30 | 404999000.0 | +156.0% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2025-09-30 | 987371000.0 | +143.8% | USD | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 104222000.0 | — | USD | 10-K | 2019-02-14 |
| Annual | 2017-12-31 | -313142000.0 | -400.5% | USD | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 109493000.0 | +135.0% | USD | 10-K | 2021-02-09 |
| Annual | 2019-12-31 | 446906000.0 | +308.2% | USD | 10-K | 2022-02-08 |
| Annual | 2020-12-31 | -295697000.0 | -166.2% | USD | 10-K | 2023-02-07 |
| Annual | 2021-12-31 | 948581000.0 | +420.8% | USD | 10-K | 2024-02-13 |
| Annual | 2022-12-31 | 340660000.0 | -64.1% | USD | 10-K | 2025-02-10 |
| Annual | 2023-12-31 | 597599000.0 | +75.4% | USD | 10-K | 2026-02-10 |
| Annual | 2024-12-31 | 32615000.0 | -94.5% | USD | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 1286650000.0 | +3845.0% | USD | 10-K | 2026-02-10 |
EPS Basic
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.13 | — | USD/shares | 10-Q | 2017-05-04 |
| Quarterly | 2016-06-30 | 0.18 | +38.5% | USD/shares | 10-Q | 2017-08-01 |
| Quarterly | 2016-09-30 | 0.2 | +11.1% | USD/shares | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | -0.96 | -580.0% | USD/shares | 10-Q | 2017-05-04 |
| Quarterly | 2017-06-30 | -0.06 | +93.7% | USD/shares | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 0.17 | +383.3% | USD/shares | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | -0.19 | -211.8% | USD/shares | 10-Q | 2019-04-30 |
| Quarterly | 2018-06-30 | 0.25 | +231.6% | USD/shares | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 0.14 | -44.0% | USD/shares | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 0.48 | +242.9% | USD/shares | 10-Q | 2020-05-05 |
| Quarterly | 2019-06-30 | 0.49 | +2.1% | USD/shares | 10-Q | 2020-08-04 |
| Quarterly | 2019-09-30 | 0.6 | +22.4% | USD/shares | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | -3.33 | -655.0% | USD/shares | 10-Q | 2021-05-04 |
| Quarterly | 2020-06-30 | 1.33 | +139.9% | USD/shares | 10-Q | 2021-08-03 |
| Quarterly | 2020-09-30 | -0.07 | -105.3% | USD/shares | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 0.24 | +442.9% | USD/shares | 10-Q | 2022-05-03 |
| Quarterly | 2021-06-30 | 0.68 | +183.3% | USD/shares | 10-Q | 2022-08-02 |
| Quarterly | 2021-09-30 | 0.82 | +20.6% | USD/shares | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 0.17 | -79.3% | USD/shares | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 0.73 | +329.4% | USD/shares | 10-Q | 2023-08-01 |
| Quarterly | 2022-09-30 | 0.51 | -30.1% | USD/shares | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 0.1 | -80.4% | USD/shares | 10-Q | 2024-04-30 |
| Quarterly | 2023-06-30 | 0.91 | +810.0% | USD/shares | 10-Q | 2024-07-30 |
| Quarterly | 2023-09-30 | 0.76 | -16.5% | USD/shares | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 0.76 | +0.0% | USD/shares | 10-Q | 2025-04-29 |
| Quarterly | 2024-06-30 | -2.04 | -368.4% | USD/shares | 10-Q | 2025-07-29 |
| Quarterly | 2024-09-30 | 0.55 | +127.0% | USD/shares | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 0.82 | +49.1% | USD/shares | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 2.09 | +154.9% | USD/shares | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 2.17 | +3.8% | USD/shares | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 0.55 | — | USD/shares | 10-K | 2019-02-14 |
| Annual | 2017-12-31 | -1.53 | -378.2% | USD/shares | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 0.52 | +134.0% | USD/shares | 10-K | 2021-02-09 |
| Annual | 2019-12-31 | 2.08 | +300.0% | USD/shares | 10-K | 2022-02-08 |
| Annual | 2020-12-31 | -1.36 | -165.4% | USD/shares | 10-K | 2023-02-07 |
| Annual | 2021-12-31 | 4.3 | +416.2% | USD/shares | 10-K | 2024-02-13 |
| Annual | 2022-12-31 | 1.53 | -64.4% | USD/shares | 10-K | 2025-02-10 |
| Annual | 2023-12-31 | 2.67 | +74.5% | USD/shares | 10-K | 2026-02-10 |
| Annual | 2024-12-31 | 0.16 | -94.0% | USD/shares | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 6.59 | +4018.8% | USD/shares | 10-K | 2026-02-10 |
EPS Diluted
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.12 | — | USD/shares | 10-Q | 2017-05-04 |
| Quarterly | 2016-06-30 | 0.18 | +50.0% | USD/shares | 10-Q | 2017-08-01 |
| Quarterly | 2016-09-30 | 0.19 | +5.6% | USD/shares | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | -0.96 | -605.3% | USD/shares | 10-Q | 2017-05-04 |
| Quarterly | 2017-06-30 | -0.06 | +93.7% | USD/shares | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 0.17 | +383.3% | USD/shares | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | -0.19 | -211.8% | USD/shares | 10-Q | 2019-04-30 |
| Quarterly | 2018-06-30 | 0.24 | +226.3% | USD/shares | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 0.14 | -41.7% | USD/shares | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 0.47 | +235.7% | USD/shares | 10-Q | 2020-05-05 |
| Quarterly | 2019-06-30 | 0.48 | +2.1% | USD/shares | 10-Q | 2020-08-04 |
| Quarterly | 2019-09-30 | 0.59 | +22.9% | USD/shares | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | -3.33 | -664.4% | USD/shares | 10-Q | 2021-05-04 |
| Quarterly | 2020-06-30 | 1.32 | +139.6% | USD/shares | 10-Q | 2021-08-03 |
| Quarterly | 2020-09-30 | -0.07 | -105.3% | USD/shares | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 0.24 | +442.9% | USD/shares | 10-Q | 2022-05-03 |
| Quarterly | 2021-06-30 | 0.67 | +179.2% | USD/shares | 10-Q | 2022-08-02 |
| Quarterly | 2021-09-30 | 0.82 | +22.4% | USD/shares | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 0.17 | -79.3% | USD/shares | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 0.72 | +323.5% | USD/shares | 10-Q | 2023-08-01 |
| Quarterly | 2022-09-30 | 0.5 | -30.6% | USD/shares | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 0.1 | -80.0% | USD/shares | 10-Q | 2024-04-30 |
| Quarterly | 2023-06-30 | 0.9 | +800.0% | USD/shares | 10-Q | 2024-07-30 |
| Quarterly | 2023-09-30 | 0.76 | -15.6% | USD/shares | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 0.75 | -1.3% | USD/shares | 10-Q | 2025-04-29 |
| Quarterly | 2024-06-30 | -2.04 | -372.0% | USD/shares | 10-Q | 2025-07-29 |
| Quarterly | 2024-09-30 | 0.54 | +126.5% | USD/shares | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 0.8 | +48.1% | USD/shares | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 2.04 | +155.0% | USD/shares | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 2.11 | +3.4% | USD/shares | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 0.54 | — | USD/shares | 10-K | 2019-02-14 |
| Annual | 2017-12-31 | -1.53 | -383.3% | USD/shares | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 0.51 | +133.3% | USD/shares | 10-K | 2021-02-09 |
| Annual | 2019-12-31 | 2.05 | +302.0% | USD/shares | 10-K | 2022-02-08 |
| Annual | 2020-12-31 | -1.36 | -166.3% | USD/shares | 10-K | 2023-02-07 |
| Annual | 2021-12-31 | 4.27 | +414.0% | USD/shares | 10-K | 2024-02-13 |
| Annual | 2022-12-31 | 1.52 | -64.4% | USD/shares | 10-K | 2025-02-10 |
| Annual | 2023-12-31 | 2.65 | +74.3% | USD/shares | 10-K | 2026-02-10 |
| Annual | 2024-12-31 | 0.15 | -94.3% | USD/shares | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 6.41 | +4173.3% | USD/shares | 10-K | 2026-02-10 |
Balance Sheet
Metrics: 9Cash and Equivalents
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 657615000.0 | — | USD | 10-Q | 2017-05-04 |
| Quarterly | 2016-06-30 | 487654000.0 | -25.8% | USD | 10-Q | 2017-08-01 |
| Quarterly | 2016-09-30 | 580099000.0 | +19.0% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2016-12-31 | 652343000.0 | +12.5% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | 361823000.0 | -44.5% | USD | 10-Q | 2017-05-04 |
| Quarterly | 2017-06-30 | 451754000.0 | +24.9% | USD | 10-Q | 2017-08-01 |
| Quarterly | 2017-09-30 | 1128046000.0 | +149.7% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2017-12-31 | 899509000.0 | -20.3% | USD | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | 894427000.0 | -0.6% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 928517000.0 | +3.8% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2018-09-30 | 1112179000.0 | +19.8% | USD | 10-Q | 2018-10-30 |
| Quarterly | 2018-12-31 | 1163980000.0 | +4.7% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 1299704000.0 | +11.7% | USD | 10-Q | 2019-04-30 |
| Quarterly | 2019-06-30 | 1416224000.0 | +9.0% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2019-09-30 | 1702023000.0 | +20.2% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2019-12-31 | 1832684000.0 | +7.7% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 1043241000.0 | -43.1% | USD | 10-Q | 2020-05-05 |
| Quarterly | 2020-06-30 | 1326730000.0 | +27.2% | USD | 10-Q | 2020-08-04 |
| Quarterly | 2020-09-30 | 1497775000.0 | +12.9% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-12-31 | 1513008000.0 | +1.0% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 1669968000.0 | +10.4% | USD | 10-Q | 2021-05-04 |
| Quarterly | 2021-06-30 | 1797582000.0 | +7.6% | USD | 10-Q | 2021-08-03 |
| Quarterly | 2021-09-30 | 1999021000.0 | +11.2% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2021-12-31 | 2057440000.0 | +2.9% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 2256759000.0 | +9.7% | USD | 10-Q | 2022-05-03 |
| Quarterly | 2022-06-30 | 2435381000.0 | +7.9% | USD | 10-Q | 2022-08-02 |
| Quarterly | 2022-09-30 | 2690622000.0 | +10.5% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2022-12-31 | 2951422000.0 | +9.7% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 2821051000.0 | -4.4% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 3131123000.0 | +11.0% | USD | 10-Q | 2023-08-01 |
| Quarterly | 2023-09-30 | 3227230000.0 | +3.1% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2023-12-31 | 3213376000.0 | -0.4% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 3346204000.0 | +4.1% | USD | 10-Q | 2024-04-30 |
| Quarterly | 2024-06-30 | 987293000.0 | -70.5% | USD | 10-Q | 2024-07-30 |
| Quarterly | 2024-09-30 | 1304109000.0 | +32.1% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2024-12-31 | 1687829000.0 | +29.4% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 1941722000.0 | +15.0% | USD | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 1954969000.0 | +0.7% | USD | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 2455006000.0 | +25.6% | USD | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 652343000.0 | — | USD | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 899509000.0 | +37.9% | USD | 10-K | 2019-02-14 |
| Annual | 2018-12-31 | 1163980000.0 | +29.4% | USD | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 1832684000.0 | +57.4% | USD | 10-K | 2021-02-09 |
| Annual | 2020-12-31 | 1513008000.0 | -17.4% | USD | 10-K | 2022-02-08 |
| Annual | 2021-12-31 | 2057440000.0 | +36.0% | USD | 10-K | 2023-02-07 |
| Annual | 2022-12-31 | 2951422000.0 | +43.5% | USD | 10-K | 2024-02-13 |
| Annual | 2023-12-31 | 3213376000.0 | +8.9% | USD | 10-K | 2025-02-10 |
| Annual | 2024-12-31 | 1687829000.0 | -47.5% | USD | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 3097817000.0 | +83.5% | USD | 10-K | 2026-02-10 |
Accounts Receivable
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|
Inventory
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 1309000.0 | — | USD | 10-Q | 2016-05-09 |
| Quarterly | 2016-06-30 | 6124000.0 | +367.8% | USD | 10-Q | 2016-08-09 |
| Quarterly | 2016-09-30 | 4078000.0 | -33.4% | USD | 10-Q | 2016-11-01 |
| Quarterly | 2016-12-31 | 4106000.0 | +0.7% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | 3961000.0 | -3.5% | USD | 10-Q | 2017-05-04 |
| Quarterly | 2017-06-30 | 2930000.0 | -26.0% | USD | 10-Q | 2017-08-01 |
| Quarterly | 2017-09-30 | 3261000.0 | +11.3% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2017-12-31 | 6482000.0 | +98.8% | USD | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | 4632000.0 | -28.5% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 5869000.0 | +26.7% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2018-09-30 | 5993000.0 | +2.1% | USD | 10-Q | 2018-10-30 |
| Quarterly | 2018-12-31 | 6967000.0 | +16.3% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 7129000.0 | +2.3% | USD | 10-Q | 2019-04-30 |
| Quarterly | 2019-06-30 | 6527000.0 | -8.4% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2019-09-30 | 7365000.0 | +12.8% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2019-12-31 | 11400000.0 | +54.8% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 13977000.0 | +22.6% | USD | 10-Q | 2020-05-05 |
| Quarterly | 2020-06-30 | 16335000.0 | +16.9% | USD | 10-Q | 2020-08-04 |
| Quarterly | 2020-09-30 | 17012000.0 | +4.1% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-12-31 | 16425000.0 | -3.5% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 16700000.0 | +1.7% | USD | 10-Q | 2021-05-04 |
| Quarterly | 2021-06-30 | 16675000.0 | -0.1% | USD | 10-Q | 2021-08-03 |
| Quarterly | 2021-09-30 | 21303000.0 | +27.8% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2021-12-31 | 27904000.0 | +31.0% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 35457000.0 | +27.1% | USD | 10-Q | 2022-05-03 |
| Quarterly | 2022-06-30 | 54502000.0 | +53.7% | USD | 10-Q | 2022-08-02 |
| Quarterly | 2022-09-30 | 45869000.0 | -15.8% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2022-12-31 | 41995000.0 | -8.4% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 40876000.0 | -2.7% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 35937000.0 | -12.1% | USD | 10-Q | 2023-08-01 |
| Quarterly | 2023-09-30 | 57200000.0 | +59.2% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2023-12-31 | 62972000.0 | +10.1% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 63642000.0 | +1.1% | USD | 10-Q | 2024-04-30 |
| Quarterly | 2024-06-30 | 100704000.0 | +58.2% | USD | 10-Q | 2024-07-30 |
| Quarterly | 2024-09-30 | 70442000.0 | -30.1% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2024-12-31 | 58872000.0 | -16.4% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 63975000.0 | +8.7% | USD | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 83423000.0 | +30.4% | USD | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 83447000.0 | +0.0% | USD | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 4106000.0 | — | USD | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 6482000.0 | +57.9% | USD | 10-K | 2019-02-14 |
| Annual | 2018-12-31 | 6967000.0 | +7.5% | USD | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 11400000.0 | +63.6% | USD | 10-K | 2021-02-09 |
| Annual | 2020-12-31 | 16425000.0 | +44.1% | USD | 10-K | 2022-02-08 |
| Annual | 2021-12-31 | 27904000.0 | +69.9% | USD | 10-K | 2023-02-07 |
| Annual | 2022-12-31 | 41995000.0 | +50.5% | USD | 10-K | 2024-02-13 |
| Annual | 2023-12-31 | 62972000.0 | +50.0% | USD | 10-K | 2025-02-10 |
| Annual | 2024-12-31 | 58872000.0 | -6.5% | USD | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 101060000.0 | +71.7% | USD | 10-K | 2026-02-10 |
Current Assets
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 935581000.0 | — | USD | 10-Q | 2016-05-09 |
| Quarterly | 2016-06-30 | 792130000.0 | -15.3% | USD | 10-Q | 2016-08-09 |
| Quarterly | 2016-09-30 | 886660000.0 | +11.9% | USD | 10-Q | 2016-11-01 |
| Quarterly | 2016-12-31 | 994178000.0 | +12.1% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | 819175000.0 | -17.6% | USD | 10-Q | 2017-05-04 |
| Quarterly | 2017-06-30 | 844803000.0 | +3.1% | USD | 10-Q | 2017-08-01 |
| Quarterly | 2017-09-30 | 1541322000.0 | +82.4% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2017-12-31 | 1504854000.0 | -2.4% | USD | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | 1469555000.0 | -2.3% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 1598084000.0 | +8.7% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2018-09-30 | 1700359000.0 | +6.4% | USD | 10-Q | 2018-10-30 |
| Quarterly | 2018-12-31 | 1832254000.0 | +7.8% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 1904500000.0 | +3.9% | USD | 10-Q | 2019-04-30 |
| Quarterly | 2019-06-30 | 2058625000.0 | +8.1% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2019-09-30 | 2319595000.0 | +12.7% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2019-12-31 | 2481488000.0 | +7.0% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 1716169000.0 | -30.8% | USD | 10-Q | 2020-05-05 |
| Quarterly | 2020-06-30 | 2077625000.0 | +21.1% | USD | 10-Q | 2020-08-04 |
| Quarterly | 2020-09-30 | 2159425000.0 | +3.9% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-12-31 | 2359894000.0 | +9.3% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 2449969000.0 | +3.8% | USD | 10-Q | 2021-05-04 |
| Quarterly | 2021-06-30 | 2620060000.0 | +6.9% | USD | 10-Q | 2021-08-03 |
| Quarterly | 2021-09-30 | 2923797000.0 | +11.6% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2021-12-31 | 3118674000.0 | +6.7% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 3288091000.0 | +5.4% | USD | 10-Q | 2022-05-03 |
| Quarterly | 2022-06-30 | 3625845000.0 | +10.3% | USD | 10-Q | 2022-08-02 |
| Quarterly | 2022-09-30 | 3821111000.0 | +5.4% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2022-12-31 | 4092850000.0 | +7.1% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 3971633000.0 | -3.0% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 4264433000.0 | +7.4% | USD | 10-Q | 2023-08-01 |
| Quarterly | 2023-09-30 | 4402665000.0 | +3.2% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2023-12-31 | 4645402000.0 | +5.5% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 4849091000.0 | +4.4% | USD | 10-Q | 2024-04-30 |
| Quarterly | 2024-06-30 | 2567085000.0 | -47.1% | USD | 10-Q | 2024-07-30 |
| Quarterly | 2024-09-30 | 2808708000.0 | +9.4% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2024-12-31 | 3239030000.0 | +15.3% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 3507421000.0 | +8.3% | USD | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 3643701000.0 | +3.9% | USD | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 4277889000.0 | +17.4% | USD | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 994178000.0 | — | USD | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 1504854000.0 | +51.4% | USD | 10-K | 2019-02-14 |
| Annual | 2018-12-31 | 1832254000.0 | +21.8% | USD | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 2481488000.0 | +35.4% | USD | 10-K | 2021-02-09 |
| Annual | 2020-12-31 | 2359894000.0 | -4.9% | USD | 10-K | 2022-02-08 |
| Annual | 2021-12-31 | 3118674000.0 | +32.2% | USD | 10-K | 2023-02-07 |
| Annual | 2022-12-31 | 4092850000.0 | +31.2% | USD | 10-K | 2024-02-13 |
| Annual | 2023-12-31 | 4645402000.0 | +13.5% | USD | 10-K | 2025-02-10 |
| Annual | 2024-12-31 | 3239030000.0 | -30.3% | USD | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 5023902000.0 | +55.1% | USD | 10-K | 2026-02-10 |
Total Assets
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 1103942000.0 | — | USD | 10-Q | 2016-05-09 |
| Quarterly | 2016-06-30 | 1417975000.0 | +28.4% | USD | 10-Q | 2016-08-09 |
| Quarterly | 2016-09-30 | 1544195000.0 | +8.9% | USD | 10-Q | 2016-11-01 |
| Quarterly | 2016-12-31 | 1638597000.0 | +6.1% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | 1607347000.0 | -1.9% | USD | 10-Q | 2017-05-04 |
| Quarterly | 2017-06-30 | 1639443000.0 | +2.0% | USD | 10-Q | 2017-08-01 |
| Quarterly | 2017-09-30 | 2374301000.0 | +44.8% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2017-12-31 | 2302582000.0 | -3.0% | USD | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | 2306012000.0 | +0.1% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 2397157000.0 | +4.0% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2018-09-30 | 2519947000.0 | +5.1% | USD | 10-Q | 2018-10-30 |
| Quarterly | 2018-12-31 | 2645762000.0 | +5.0% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 2754161000.0 | +4.1% | USD | 10-Q | 2019-04-30 |
| Quarterly | 2019-06-30 | 2947633000.0 | +7.0% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2019-09-30 | 3214818000.0 | +9.1% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2019-12-31 | 3426750000.0 | +6.6% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 2752422000.0 | -19.7% | USD | 10-Q | 2020-05-05 |
| Quarterly | 2020-06-30 | 3212321000.0 | +16.7% | USD | 10-Q | 2020-08-04 |
| Quarterly | 2020-09-30 | 3307430000.0 | +3.0% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-12-31 | 3560918000.0 | +7.7% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 3661436000.0 | +2.8% | USD | 10-Q | 2021-05-04 |
| Quarterly | 2021-06-30 | 3904623000.0 | +6.6% | USD | 10-Q | 2021-08-03 |
| Quarterly | 2021-09-30 | 4198831000.0 | +7.5% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2021-12-31 | 4933352000.0 | +17.5% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 5054221000.0 | +2.5% | USD | 10-Q | 2022-05-03 |
| Quarterly | 2022-06-30 | 5319035000.0 | +5.2% | USD | 10-Q | 2022-08-02 |
| Quarterly | 2022-09-30 | 5510214000.0 | +3.6% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2022-12-31 | 5840984000.0 | +6.0% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 5797623000.0 | -0.7% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 6208259000.0 | +7.1% | USD | 10-Q | 2023-08-01 |
| Quarterly | 2023-09-30 | 6388239000.0 | +2.9% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2023-12-31 | 6782107000.0 | +6.2% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 7135605000.0 | +5.2% | USD | 10-Q | 2024-04-30 |
| Quarterly | 2024-06-30 | 4661803000.0 | -34.7% | USD | 10-Q | 2024-07-30 |
| Quarterly | 2024-09-30 | 5012434000.0 | +7.5% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2024-12-31 | 5444322000.0 | +8.6% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 5749365000.0 | +5.6% | USD | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 5821354000.0 | +1.3% | USD | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 6330356000.0 | +8.7% | USD | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 1638597000.0 | — | USD | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 2302582000.0 | +40.5% | USD | 10-K | 2019-02-14 |
| Annual | 2018-12-31 | 2645762000.0 | +14.9% | USD | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 3426750000.0 | +29.5% | USD | 10-K | 2021-02-09 |
| Annual | 2020-12-31 | 3560918000.0 | +3.9% | USD | 10-K | 2022-02-08 |
| Annual | 2021-12-31 | 4933352000.0 | +38.5% | USD | 10-K | 2023-02-07 |
| Annual | 2022-12-31 | 5840984000.0 | +18.4% | USD | 10-K | 2024-02-13 |
| Annual | 2023-12-31 | 6782107000.0 | +16.1% | USD | 10-K | 2025-02-10 |
| Annual | 2024-12-31 | 5444322000.0 | -19.7% | USD | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 6957973000.0 | +27.8% | USD | 10-K | 2026-02-10 |
Current Liabilities
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 200319000.0 | — | USD | 10-Q | 2016-05-09 |
| Quarterly | 2016-06-30 | 198986000.0 | -0.7% | USD | 10-Q | 2016-08-09 |
| Quarterly | 2016-09-30 | 240545000.0 | +20.9% | USD | 10-Q | 2016-11-01 |
| Quarterly | 2016-12-31 | 273501000.0 | +13.7% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | 304716000.0 | +11.4% | USD | 10-Q | 2017-05-04 |
| Quarterly | 2017-06-30 | 293161000.0 | -3.8% | USD | 10-Q | 2017-08-01 |
| Quarterly | 2017-09-30 | 319935000.0 | +9.1% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2017-12-31 | 375396000.0 | +17.3% | USD | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | 381072000.0 | +1.5% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 368239000.0 | -3.4% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2018-09-30 | 422489000.0 | +14.7% | USD | 10-Q | 2018-10-30 |
| Quarterly | 2018-12-31 | 425277000.0 | +0.7% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 364515000.0 | -14.3% | USD | 10-Q | 2019-04-30 |
| Quarterly | 2019-06-30 | 367105000.0 | +0.7% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2019-09-30 | 461683000.0 | +25.8% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2019-12-31 | 513340000.0 | +11.2% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 503412000.0 | -1.9% | USD | 10-Q | 2020-05-05 |
| Quarterly | 2020-06-30 | 556513000.0 | +10.5% | USD | 10-Q | 2020-08-04 |
| Quarterly | 2020-09-30 | 606202000.0 | +8.9% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-12-31 | 631195000.0 | +4.1% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 623881000.0 | -1.2% | USD | 10-Q | 2021-05-04 |
| Quarterly | 2021-06-30 | 660324000.0 | +5.8% | USD | 10-Q | 2021-08-03 |
| Quarterly | 2021-09-30 | 742712000.0 | +12.5% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2021-12-31 | 854308000.0 | +15.0% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 886163000.0 | +3.7% | USD | 10-Q | 2022-05-03 |
| Quarterly | 2022-06-30 | 926674000.0 | +4.6% | USD | 10-Q | 2022-08-02 |
| Quarterly | 2022-09-30 | 1006596000.0 | +8.6% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2022-12-31 | 1157077000.0 | +14.9% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 1006111000.0 | -13.0% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 1118773000.0 | +11.2% | USD | 10-Q | 2023-08-01 |
| Quarterly | 2023-09-30 | 1124680000.0 | +0.5% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2023-12-31 | 1240379000.0 | +10.3% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 1396453000.0 | +12.6% | USD | 10-Q | 2024-04-30 |
| Quarterly | 2024-06-30 | 1337055000.0 | -4.3% | USD | 10-Q | 2024-07-30 |
| Quarterly | 2024-09-30 | 1501650000.0 | +12.3% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2024-12-31 | 1641847000.0 | +9.3% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 1720290000.0 | +4.8% | USD | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 1278619000.0 | -25.7% | USD | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 1338729000.0 | +4.7% | USD | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 273501000.0 | — | USD | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 375396000.0 | +37.3% | USD | 10-K | 2019-02-14 |
| Annual | 2018-12-31 | 425277000.0 | +13.3% | USD | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 513340000.0 | +20.7% | USD | 10-K | 2021-02-09 |
| Annual | 2020-12-31 | 631195000.0 | +23.0% | USD | 10-K | 2022-02-08 |
| Annual | 2021-12-31 | 854308000.0 | +35.3% | USD | 10-K | 2023-02-07 |
| Annual | 2022-12-31 | 1157077000.0 | +35.4% | USD | 10-K | 2024-02-13 |
| Annual | 2023-12-31 | 1240379000.0 | +7.2% | USD | 10-K | 2025-02-10 |
| Annual | 2024-12-31 | 1641847000.0 | +32.4% | USD | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 1515170000.0 | -7.7% | USD | 10-K | 2026-02-10 |
Total Liabilities
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 876194000.0 | — | USD | 10-Q | 2016-05-09 |
| Quarterly | 2016-06-30 | 1120912000.0 | +27.9% | USD | 10-Q | 2016-08-09 |
| Quarterly | 2016-09-30 | 1174209000.0 | +4.8% | USD | 10-Q | 2016-11-01 |
| Quarterly | 2016-12-31 | 1219130000.0 | +3.8% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | 641413000.0 | -47.4% | USD | 10-Q | 2017-05-04 |
| Quarterly | 2017-06-30 | 612608000.0 | -4.5% | USD | 10-Q | 2017-08-01 |
| Quarterly | 2017-09-30 | 616551000.0 | +0.6% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2017-12-31 | 671953000.0 | +9.0% | USD | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | 677968000.0 | +0.9% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 664234000.0 | -2.0% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2018-09-30 | 717048000.0 | +8.0% | USD | 10-Q | 2018-10-30 |
| Quarterly | 2018-12-31 | 719795000.0 | +0.4% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 668594000.0 | -7.1% | USD | 10-Q | 2019-04-30 |
| Quarterly | 2019-06-30 | 700442000.0 | +4.8% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2019-09-30 | 792291000.0 | +13.1% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2019-12-31 | 828344000.0 | +4.6% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 814701000.0 | -1.6% | USD | 10-Q | 2020-05-05 |
| Quarterly | 2020-06-30 | 867717000.0 | +6.5% | USD | 10-Q | 2020-08-04 |
| Quarterly | 2020-09-30 | 916597000.0 | +5.6% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-12-31 | 949650000.0 | +3.6% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 933592000.0 | -1.7% | USD | 10-Q | 2021-05-04 |
| Quarterly | 2021-06-30 | 968762000.0 | +3.8% | USD | 10-Q | 2021-08-03 |
| Quarterly | 2021-09-30 | 1050174000.0 | +8.4% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2021-12-31 | 1163348000.0 | +10.8% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 1191149000.0 | +2.4% | USD | 10-Q | 2022-05-03 |
| Quarterly | 2022-06-30 | 1233974000.0 | +3.6% | USD | 10-Q | 2022-08-02 |
| Quarterly | 2022-09-30 | 1283563000.0 | +4.0% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2022-12-31 | 1470865000.0 | +14.6% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 1335055000.0 | -9.2% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 1467567000.0 | +9.9% | USD | 10-Q | 2023-08-01 |
| Quarterly | 2023-09-30 | 1456792000.0 | -0.7% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2023-12-31 | 1592270000.0 | +9.3% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 1741334000.0 | +9.4% | USD | 10-Q | 2024-04-30 |
| Quarterly | 2024-06-30 | 1664744000.0 | -4.4% | USD | 10-Q | 2024-07-30 |
| Quarterly | 2024-09-30 | 1841214000.0 | +10.6% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2024-12-31 | 1996694000.0 | +8.4% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 2081802000.0 | +4.3% | USD | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 1650451000.0 | -20.7% | USD | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 1679162000.0 | +1.7% | USD | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 1219130000.0 | — | USD | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 671953000.0 | -44.9% | USD | 10-K | 2019-02-14 |
| Annual | 2018-12-31 | 719795000.0 | +7.1% | USD | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 828344000.0 | +15.1% | USD | 10-K | 2021-02-09 |
| Annual | 2020-12-31 | 949650000.0 | +14.6% | USD | 10-K | 2022-02-08 |
| Annual | 2021-12-31 | 1163348000.0 | +22.5% | USD | 10-K | 2023-02-07 |
| Annual | 2022-12-31 | 1470865000.0 | +26.4% | USD | 10-K | 2024-02-13 |
| Annual | 2023-12-31 | 1592270000.0 | +8.3% | USD | 10-K | 2025-02-10 |
| Annual | 2024-12-31 | 1996694000.0 | +25.4% | USD | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 1790495000.0 | -10.3% | USD | 10-K | 2026-02-10 |
Stockholders' Equity
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 227748000.0 | — | USD | 10-Q | 2016-05-09 |
| Quarterly | 2016-06-30 | 297063000.0 | +30.4% | USD | 10-Q | 2016-08-09 |
| Quarterly | 2016-09-30 | 369986000.0 | +24.5% | USD | 10-Q | 2016-11-01 |
| Quarterly | 2016-12-31 | 419467000.0 | +13.4% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | 965934000.0 | +130.3% | USD | 10-Q | 2017-05-04 |
| Quarterly | 2017-06-30 | 1026835000.0 | +6.3% | USD | 10-Q | 2017-08-01 |
| Quarterly | 2017-09-30 | 1757750000.0 | +71.2% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2017-12-31 | 1630629000.0 | -7.2% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2018-03-31 | 1628044000.0 | -0.2% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2018-06-30 | 1732923000.0 | +6.4% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2018-09-30 | 1802899000.0 | +4.0% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2018-12-31 | 1925967000.0 | +6.8% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2019-03-31 | 2085567000.0 | +8.3% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2019-06-30 | 2247191000.0 | +7.7% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2019-09-30 | 2422527000.0 | +7.8% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2019-12-31 | 2598406000.0 | +7.3% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2020-03-31 | 1937721000.0 | -25.4% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2020-06-30 | 2344604000.0 | +21.0% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2020-09-30 | 2390833000.0 | +2.0% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2020-12-31 | 2611268000.0 | +9.2% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2021-03-31 | 2727844000.0 | +4.5% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2021-06-30 | 2935861000.0 | +7.6% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2021-09-30 | 3148657000.0 | +7.2% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2021-12-31 | 3770004000.0 | +19.7% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2022-03-31 | 3863072000.0 | +2.5% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2022-06-30 | 4085061000.0 | +5.7% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2022-09-30 | 4226651000.0 | +3.5% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2022-12-31 | 4370119000.0 | +3.4% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2023-03-31 | 4462568000.0 | +2.1% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2023-06-30 | 4740692000.0 | +6.2% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2023-09-30 | 4931447000.0 | +4.0% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2023-12-31 | 5189837000.0 | +5.2% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2024-03-31 | 5394271000.0 | +3.9% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2024-06-30 | 2997059000.0 | -44.4% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2024-09-30 | 3171220000.0 | +5.8% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2024-12-31 | 3447628000.0 | +8.7% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 3667563000.0 | +6.4% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2025-06-30 | 4170903000.0 | +13.7% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2025-09-30 | 4651194000.0 | +11.5% | USD | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 419467000.0 | — | USD | 10-K | 2020-02-13 |
| Annual | 2017-12-31 | 1630629000.0 | +288.7% | USD | 10-K | 2021-02-09 |
| Annual | 2018-12-31 | 1925967000.0 | +18.1% | USD | 10-K | 2022-02-08 |
| Annual | 2019-12-31 | 2598406000.0 | +34.9% | USD | 10-K | 2023-02-07 |
| Annual | 2020-12-31 | 2611268000.0 | +0.5% | USD | 10-K | 2024-02-13 |
| Annual | 2021-12-31 | 3770004000.0 | +44.4% | USD | 10-K | 2025-02-10 |
| Annual | 2022-12-31 | 4370119000.0 | +15.9% | USD | 10-K | 2026-02-10 |
| Annual | 2023-12-31 | 5189837000.0 | +18.8% | USD | 10-K | 2026-02-10 |
| Annual | 2024-12-31 | 3447628000.0 | -33.6% | USD | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 5167478000.0 | +49.9% | USD | 10-K | 2026-02-10 |
Long-Term Debt
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Annual | 2016-12-31 | 749800000.0 | — | USD | 10-K | 2017-02-14 |
| Annual | 2017-12-31 | 26800000.0 | -96.4% | USD | 10-K | 2018-02-15 |
| Annual | 2018-12-31 | 19094000000.0 | +71146.3% | USD | 10-K | 2019-02-14 |
Cash Flow
Metrics: 4Operating Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-06-30 | 115107000.0 | — | USD | 10-Q | 2017-08-01 |
| Quarterly | 2016-09-30 | 210378000.0 | +82.8% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | -173638000.0 | -182.5% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | -56844000.0 | +67.3% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | -3721000.0 | +93.5% | USD | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | 20838000.0 | +660.0% | USD | 10-Q | 2019-04-30 |
| Quarterly | 2018-06-30 | 53241000.0 | +155.5% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 252389000.0 | +374.1% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 155663000.0 | -38.3% | USD | 10-Q | 2020-05-05 |
| Quarterly | 2019-06-30 | 308623000.0 | +98.3% | USD | 10-Q | 2020-08-04 |
| Quarterly | 2019-09-30 | 579038000.0 | +87.6% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | -683417000.0 | -218.0% | USD | 10-Q | 2021-05-04 |
| Quarterly | 2020-06-30 | -414035000.0 | +39.4% | USD | 10-Q | 2021-08-03 |
| Quarterly | 2020-09-30 | -231920000.0 | +44.0% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 206095000.0 | +188.9% | USD | 10-Q | 2022-05-03 |
| Quarterly | 2021-06-30 | 379039000.0 | +83.9% | USD | 10-Q | 2022-08-02 |
| Quarterly | 2021-09-30 | 634137000.0 | +67.3% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 215741000.0 | -66.0% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 389898000.0 | +80.7% | USD | 10-Q | 2023-08-01 |
| Quarterly | 2022-09-30 | 686279000.0 | +76.0% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | -105603000.0 | -115.4% | USD | 10-Q | 2024-04-30 |
| Quarterly | 2023-06-30 | 200923000.0 | +290.3% | USD | 10-Q | 2024-07-30 |
| Quarterly | 2023-09-30 | 348758000.0 | +73.6% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 218811000.0 | -37.3% | USD | 10-Q | 2025-04-29 |
| Quarterly | 2024-06-30 | -356752000.0 | -263.0% | USD | 10-Q | 2025-07-29 |
| Quarterly | 2024-09-30 | -45881000.0 | +87.1% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 266067000.0 | +679.9% | USD | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 310808000.0 | +16.8% | USD | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 870197000.0 | +180.0% | USD | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 304756000.0 | — | USD | 10-K | 2019-02-14 |
| Annual | 2017-12-31 | -92988000.0 | -130.5% | USD | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 336227000.0 | +461.6% | USD | 10-K | 2021-02-09 |
| Annual | 2019-12-31 | 710656000.0 | +111.4% | USD | 10-K | 2022-02-08 |
| Annual | 2020-12-31 | -124599000.0 | -117.5% | USD | 10-K | 2023-02-07 |
| Annual | 2021-12-31 | 749488000.0 | +701.5% | USD | 10-K | 2024-02-13 |
| Annual | 2022-12-31 | 969941000.0 | +29.4% | USD | 10-K | 2025-02-10 |
| Annual | 2023-12-31 | 496487000.0 | -48.8% | USD | 10-K | 2026-02-10 |
| Annual | 2024-12-31 | 335337000.0 | -32.5% | USD | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 1413498000.0 | +321.5% | USD | 10-K | 2026-02-10 |
Investing Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-06-30 | -186524000.0 | — | USD | 10-Q | 2017-08-01 |
| Quarterly | 2016-09-30 | -196476000.0 | -5.3% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | -138819000.0 | +29.3% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | -176137000.0 | -26.9% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | -206976000.0 | -17.5% | USD | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | -28528000.0 | +86.2% | USD | 10-Q | 2019-04-30 |
| Quarterly | 2018-06-30 | -32450000.0 | -13.7% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | -50326000.0 | -55.1% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | -24563000.0 | +51.2% | USD | 10-Q | 2020-05-05 |
| Quarterly | 2019-06-30 | -69710000.0 | -183.8% | USD | 10-Q | 2020-08-04 |
| Quarterly | 2019-09-30 | -57426000.0 | +17.6% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | -108560000.0 | -89.0% | USD | 10-Q | 2021-05-04 |
| Quarterly | 2020-06-30 | -151818000.0 | -39.8% | USD | 10-Q | 2021-08-03 |
| Quarterly | 2020-09-30 | -166271000.0 | -9.5% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | -59753000.0 | +64.1% | USD | 10-Q | 2022-05-03 |
| Quarterly | 2021-06-30 | -108898000.0 | -82.2% | USD | 10-Q | 2022-08-02 |
| Quarterly | 2021-09-30 | -141652000.0 | -30.1% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | -16748000.0 | +88.2% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | -29228000.0 | -74.5% | USD | 10-Q | 2023-08-01 |
| Quarterly | 2022-09-30 | -57630000.0 | -97.2% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | -28559000.0 | +50.4% | USD | 10-Q | 2024-04-30 |
| Quarterly | 2023-06-30 | -35988000.0 | -26.0% | USD | 10-Q | 2024-07-30 |
| Quarterly | 2023-09-30 | -53177000.0 | -47.8% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | -73112000.0 | -37.5% | USD | 10-Q | 2025-04-29 |
| Quarterly | 2024-06-30 | 140708000.0 | +292.5% | USD | 10-Q | 2025-07-29 |
| Quarterly | 2024-09-30 | 178982000.0 | +27.2% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 1097000.0 | -99.4% | USD | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | -17775000.0 | -1720.3% | USD | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | -65191000.0 | -266.8% | USD | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | -232488000.0 | — | USD | 10-K | 2019-02-14 |
| Annual | 2017-12-31 | -349978000.0 | -50.5% | USD | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | -86423000.0 | +75.3% | USD | 10-K | 2021-02-09 |
| Annual | 2019-12-31 | -87454000.0 | -1.2% | USD | 10-K | 2022-02-08 |
| Annual | 2020-12-31 | -269001000.0 | -207.6% | USD | 10-K | 2023-02-07 |
| Annual | 2021-12-31 | -207699000.0 | +22.8% | USD | 10-K | 2024-02-13 |
| Annual | 2022-12-31 | -78542000.0 | +62.2% | USD | 10-K | 2025-02-10 |
| Annual | 2023-12-31 | -207677000.0 | -164.4% | USD | 10-K | 2026-02-10 |
| Annual | 2024-12-31 | 157517000.0 | +175.8% | USD | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | -102610000.0 | -165.1% | USD | 10-K | 2026-02-10 |
Financing Cash Flow
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-06-30 | 37647000.0 | — | USD | 10-Q | 2017-08-01 |
| Quarterly | 2016-09-30 | 44773000.0 | +18.9% | USD | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | 21960000.0 | -51.0% | USD | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 32492000.0 | +48.0% | USD | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 686486000.0 | +2012.8% | USD | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | 2595000.0 | -99.6% | USD | 10-Q | 2019-04-30 |
| Quarterly | 2018-06-30 | 8157000.0 | +214.3% | USD | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 10594000.0 | +29.9% | USD | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 4487000.0 | -57.6% | USD | 10-Q | 2020-05-05 |
| Quarterly | 2019-06-30 | 13497000.0 | +200.8% | USD | 10-Q | 2020-08-04 |
| Quarterly | 2019-09-30 | 16391000.0 | +21.4% | USD | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 2499000.0 | -84.8% | USD | 10-Q | 2021-05-04 |
| Quarterly | 2020-06-30 | 58906000.0 | +2257.2% | USD | 10-Q | 2021-08-03 |
| Quarterly | 2020-09-30 | 59837000.0 | +1.6% | USD | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 12835000.0 | -78.6% | USD | 10-Q | 2022-05-03 |
| Quarterly | 2021-06-30 | 16514000.0 | +28.7% | USD | 10-Q | 2022-08-02 |
| Quarterly | 2021-09-30 | -2829000.0 | -117.1% | USD | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 96000.0 | +103.4% | USD | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 15997000.0 | +16563.5% | USD | 10-Q | 2023-08-01 |
| Quarterly | 2022-09-30 | 1686000.0 | -89.5% | USD | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 4009000.0 | +137.8% | USD | 10-Q | 2024-04-30 |
| Quarterly | 2023-06-30 | 16877000.0 | +321.0% | USD | 10-Q | 2024-07-30 |
| Quarterly | 2023-09-30 | -20379000.0 | -220.8% | USD | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | -12413000.0 | +39.1% | USD | 10-Q | 2025-04-29 |
| Quarterly | 2024-06-30 | -2009590000.0 | -16089.4% | USD | 10-Q | 2025-07-29 |
| Quarterly | 2024-09-30 | -2041941000.0 | -1.6% | USD | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | -12676000.0 | +99.4% | USD | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | -23922000.0 | -88.7% | USD | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | -36700000.0 | -53.4% | USD | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 44622000.0 | — | USD | 10-K | 2019-02-14 |
| Annual | 2017-12-31 | 690210000.0 | +1446.8% | USD | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 14657000.0 | -97.9% | USD | 10-K | 2021-02-09 |
| Annual | 2019-12-31 | 45711000.0 | +211.9% | USD | 10-K | 2022-02-08 |
| Annual | 2020-12-31 | 71709000.0 | +56.9% | USD | 10-K | 2023-02-07 |
| Annual | 2021-12-31 | 6176000.0 | -91.4% | USD | 10-K | 2024-02-13 |
| Annual | 2022-12-31 | -794000.0 | -112.9% | USD | 10-K | 2025-02-10 |
| Annual | 2023-12-31 | -20033000.0 | -2423.0% | USD | 10-K | 2026-02-10 |
| Annual | 2024-12-31 | -2021547000.0 | -9991.1% | USD | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 101039000.0 | +105.0% | USD | 10-K | 2026-02-10 |
Capital Expenditures
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2024-05-31 | 48700000.0 | — | USD | 10-Q | 2025-10-28 |
| Annual | 2024-05-31 | 48700000.0 | — | USD | 10-K | 2026-02-10 |
Share Data
Metrics: 4Shares Outstanding
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 187402129.0 | — | shares | 10-Q | 2016-05-09 |
| Quarterly | 2016-06-30 | 187865985.0 | +0.2% | shares | 10-Q | 2016-08-09 |
| Quarterly | 2016-09-30 | 188258973.0 | +0.2% | shares | 10-Q | 2016-11-01 |
| Quarterly | 2016-12-31 | 188848752.0 | +0.3% | shares | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | 204563710.0 | +8.3% | shares | 10-Q | 2017-05-04 |
| Quarterly | 2017-06-30 | 205630980.0 | +0.5% | shares | 10-Q | 2017-08-01 |
| Quarterly | 2017-09-30 | 211019366.0 | +2.6% | shares | 10-Q | 2017-10-31 |
| Quarterly | 2017-12-31 | 211262906.0 | +0.1% | shares | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | 211888186.0 | +0.3% | shares | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 212409152.0 | +0.2% | shares | 10-Q | 2018-07-31 |
| Quarterly | 2018-09-30 | 212754024.0 | +0.2% | shares | 10-Q | 2018-10-30 |
| Quarterly | 2018-12-31 | 213274660.0 | +0.2% | shares | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 214320605.0 | +0.5% | shares | 10-Q | 2019-04-30 |
| Quarterly | 2019-06-30 | 214865720.0 | +0.3% | shares | 10-Q | 2019-07-30 |
| Quarterly | 2019-09-30 | 215373548.0 | +0.2% | shares | 10-Q | 2019-10-29 |
| Quarterly | 2019-12-31 | 216177830.0 | +0.4% | shares | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 216952325.0 | +0.4% | shares | 10-Q | 2020-05-05 |
| Quarterly | 2020-06-30 | 218069218.0 | +0.5% | shares | 10-Q | 2020-08-04 |
| Quarterly | 2020-09-30 | 218903097.0 | +0.4% | shares | 10-Q | 2020-11-05 |
| Quarterly | 2020-12-31 | 219489329.0 | +0.3% | shares | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 219880198.0 | +0.2% | shares | 10-Q | 2021-05-04 |
| Quarterly | 2021-06-30 | 220424569.0 | +0.2% | shares | 10-Q | 2021-08-03 |
| Quarterly | 2021-09-30 | 220885119.0 | +0.2% | shares | 10-Q | 2021-11-02 |
| Quarterly | 2021-12-31 | 221084433.0 | +0.1% | shares | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 221409550.0 | +0.1% | shares | 10-Q | 2022-05-03 |
| Quarterly | 2022-06-30 | 221875396.0 | +0.2% | shares | 10-Q | 2022-08-02 |
| Quarterly | 2022-09-30 | 222454839.0 | +0.3% | shares | 10-Q | 2022-11-01 |
| Quarterly | 2022-12-31 | 222746719.0 | +0.1% | shares | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 223061787.0 | +0.1% | shares | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 223338330.0 | +0.1% | shares | 10-Q | 2023-08-01 |
| Quarterly | 2023-09-30 | 224101839.0 | +0.3% | shares | 10-Q | 2023-10-31 |
| Quarterly | 2023-12-31 | 224286862.0 | +0.1% | shares | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 224533449.0 | +0.1% | shares | 10-Q | 2024-04-30 |
| Quarterly | 2024-06-30 | 191572449.0 | -14.7% | shares | 10-Q | 2024-07-30 |
| Quarterly | 2024-09-30 | 192798328.0 | +0.6% | shares | 10-Q | 2024-10-29 |
| Quarterly | 2024-12-31 | 193434305.0 | +0.3% | shares | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 193783446.0 | +0.2% | shares | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 194123265.0 | +0.2% | shares | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 196130993.0 | +1.0% | shares | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 188848752.0 | — | shares | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 211262906.0 | +11.9% | shares | 10-K | 2019-02-14 |
| Annual | 2018-12-31 | 213274660.0 | +1.0% | shares | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 216177830.0 | +1.4% | shares | 10-K | 2021-02-09 |
| Annual | 2020-12-31 | 219489329.0 | +1.5% | shares | 10-K | 2022-02-08 |
| Annual | 2021-12-31 | 221084433.0 | +0.7% | shares | 10-K | 2023-02-07 |
| Annual | 2022-12-31 | 222746719.0 | +0.8% | shares | 10-K | 2024-02-13 |
| Annual | 2023-12-31 | 224286862.0 | +0.7% | shares | 10-K | 2025-02-10 |
| Annual | 2024-12-31 | 193434305.0 | -13.8% | shares | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 198460009.0 | +2.6% | shares | 10-K | 2026-02-10 |
Shares Issued
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 187402129.0 | — | shares | 10-Q | 2016-05-09 |
| Quarterly | 2016-06-30 | 187865985.0 | +0.2% | shares | 10-Q | 2016-08-09 |
| Quarterly | 2016-09-30 | 188258973.0 | +0.2% | shares | 10-Q | 2016-11-01 |
| Quarterly | 2016-12-31 | 188848752.0 | +0.3% | shares | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | 204563710.0 | +8.3% | shares | 10-Q | 2017-05-04 |
| Quarterly | 2017-06-30 | 205630980.0 | +0.5% | shares | 10-Q | 2017-08-01 |
| Quarterly | 2017-09-30 | 211019366.0 | +2.6% | shares | 10-Q | 2017-10-31 |
| Quarterly | 2017-12-31 | 211262906.0 | +0.1% | shares | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | 211888186.0 | +0.3% | shares | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 212409152.0 | +0.2% | shares | 10-Q | 2018-07-31 |
| Quarterly | 2018-09-30 | 212754024.0 | +0.2% | shares | 10-Q | 2018-10-30 |
| Quarterly | 2018-12-31 | 213274660.0 | +0.2% | shares | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 214320605.0 | +0.5% | shares | 10-Q | 2019-04-30 |
| Quarterly | 2019-06-30 | 214865720.0 | +0.3% | shares | 10-Q | 2019-07-30 |
| Quarterly | 2019-09-30 | 215373548.0 | +0.2% | shares | 10-Q | 2019-10-29 |
| Quarterly | 2019-12-31 | 216177830.0 | +0.4% | shares | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 216952325.0 | +0.4% | shares | 10-Q | 2020-05-05 |
| Quarterly | 2020-06-30 | 218069218.0 | +0.5% | shares | 10-Q | 2020-08-04 |
| Quarterly | 2020-09-30 | 218903097.0 | +0.4% | shares | 10-Q | 2020-11-05 |
| Quarterly | 2020-12-31 | 219489329.0 | +0.3% | shares | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 219880198.0 | +0.2% | shares | 10-Q | 2021-05-04 |
| Quarterly | 2021-06-30 | 220424569.0 | +0.2% | shares | 10-Q | 2021-08-03 |
| Quarterly | 2021-09-30 | 220885119.0 | +0.2% | shares | 10-Q | 2021-11-02 |
| Quarterly | 2021-12-31 | 221084433.0 | +0.1% | shares | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 221409550.0 | +0.1% | shares | 10-Q | 2022-05-03 |
| Quarterly | 2022-06-30 | 221875396.0 | +0.2% | shares | 10-Q | 2022-08-02 |
| Quarterly | 2022-09-30 | 222454839.0 | +0.3% | shares | 10-Q | 2022-11-01 |
| Quarterly | 2022-12-31 | 222746719.0 | +0.1% | shares | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 223061787.0 | +0.1% | shares | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 223338330.0 | +0.1% | shares | 10-Q | 2023-08-01 |
| Quarterly | 2023-09-30 | 224101839.0 | +0.3% | shares | 10-Q | 2023-10-31 |
| Quarterly | 2023-12-31 | 224286862.0 | +0.1% | shares | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 224533449.0 | +0.1% | shares | 10-Q | 2024-04-30 |
| Quarterly | 2024-06-30 | 191572449.0 | -14.7% | shares | 10-Q | 2024-07-30 |
| Quarterly | 2024-09-30 | 192798328.0 | +0.6% | shares | 10-Q | 2024-10-29 |
| Quarterly | 2024-12-31 | 193434305.0 | +0.3% | shares | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 193783446.0 | +0.2% | shares | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 194123265.0 | +0.2% | shares | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 196130993.0 | +1.0% | shares | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 188848752.0 | — | shares | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 211262906.0 | +11.9% | shares | 10-K | 2019-02-14 |
| Annual | 2018-12-31 | 213274660.0 | +1.0% | shares | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 216177830.0 | +1.4% | shares | 10-K | 2021-02-09 |
| Annual | 2020-12-31 | 219489329.0 | +1.5% | shares | 10-K | 2022-02-08 |
| Annual | 2021-12-31 | 221084433.0 | +0.7% | shares | 10-K | 2023-02-07 |
| Annual | 2022-12-31 | 222746719.0 | +0.8% | shares | 10-K | 2024-02-13 |
| Annual | 2023-12-31 | 224286862.0 | +0.7% | shares | 10-K | 2025-02-10 |
| Annual | 2024-12-31 | 193434305.0 | -13.8% | shares | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 198460009.0 | +2.6% | shares | 10-K | 2026-02-10 |
Weighted Avg Shares Basic
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 187184000.0 | — | shares | 10-Q | 2017-05-04 |
| Quarterly | 2016-06-30 | 187682000.0 | +0.3% | shares | 10-Q | 2017-08-01 |
| Quarterly | 2016-09-30 | 188029000.0 | +0.2% | shares | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | 195260000.0 | +3.8% | shares | 10-Q | 2017-05-04 |
| Quarterly | 2017-06-30 | 205141000.0 | +5.1% | shares | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 206796000.0 | +0.8% | shares | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | 211681000.0 | +2.4% | shares | 10-Q | 2019-04-30 |
| Quarterly | 2018-06-30 | 212210000.0 | +0.2% | shares | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 212627000.0 | +0.2% | shares | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 214065000.0 | +0.7% | shares | 10-Q | 2020-05-05 |
| Quarterly | 2019-06-30 | 214620000.0 | +0.3% | shares | 10-Q | 2020-08-04 |
| Quarterly | 2019-09-30 | 215199000.0 | +0.3% | shares | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 216721000.0 | +0.7% | shares | 10-Q | 2021-05-04 |
| Quarterly | 2020-06-30 | 217549000.0 | +0.4% | shares | 10-Q | 2021-08-03 |
| Quarterly | 2020-09-30 | 218784000.0 | +0.6% | shares | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 219801000.0 | +0.5% | shares | 10-Q | 2022-05-03 |
| Quarterly | 2021-06-30 | 220083000.0 | +0.1% | shares | 10-Q | 2022-08-02 |
| Quarterly | 2021-09-30 | 220845000.0 | +0.3% | shares | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 221326000.0 | +0.2% | shares | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 221660000.0 | +0.2% | shares | 10-Q | 2023-08-01 |
| Quarterly | 2022-09-30 | 222415000.0 | +0.3% | shares | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 222960000.0 | +0.2% | shares | 10-Q | 2024-04-30 |
| Quarterly | 2023-06-30 | 223248000.0 | +0.1% | shares | 10-Q | 2024-07-30 |
| Quarterly | 2023-09-30 | 224078000.0 | +0.4% | shares | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 224484000.0 | +0.2% | shares | 10-Q | 2025-04-29 |
| Quarterly | 2024-06-30 | 218175000.0 | -2.8% | shares | 10-Q | 2025-07-29 |
| Quarterly | 2024-09-30 | 192629000.0 | -11.7% | shares | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 193712000.0 | +0.6% | shares | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 193995000.0 | +0.1% | shares | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 195670000.0 | +0.9% | shares | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 187873000.0 | — | shares | 10-K | 2019-02-14 |
| Annual | 2017-12-31 | 204580000.0 | +8.9% | shares | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 212383000.0 | +3.8% | shares | 10-K | 2021-02-09 |
| Annual | 2019-12-31 | 214913000.0 | +1.2% | shares | 10-K | 2022-02-08 |
| Annual | 2020-12-31 | 218073000.0 | +1.5% | shares | 10-K | 2023-02-07 |
| Annual | 2021-12-31 | 220428000.0 | +1.1% | shares | 10-K | 2024-02-13 |
| Annual | 2022-12-31 | 222004000.0 | +0.7% | shares | 10-K | 2025-02-10 |
| Annual | 2023-12-31 | 223628000.0 | +0.7% | shares | 10-K | 2026-02-10 |
| Annual | 2024-12-31 | 207110000.0 | -7.4% | shares | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 195204000.0 | -5.7% | shares | 10-K | 2026-02-10 |
Weighted Avg Shares Diluted
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 192625000.0 | — | shares | 10-Q | 2017-05-04 |
| Quarterly | 2016-06-30 | 193015000.0 | +0.2% | shares | 10-Q | 2017-08-01 |
| Quarterly | 2016-09-30 | 194265000.0 | +0.6% | shares | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | 195260000.0 | +0.5% | shares | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 205141000.0 | +5.1% | shares | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 212610000.0 | +3.6% | shares | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | 211681000.0 | -0.4% | shares | 10-Q | 2019-04-30 |
| Quarterly | 2018-06-30 | 215103000.0 | +1.6% | shares | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 215964000.0 | +0.4% | shares | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 217061000.0 | +0.5% | shares | 10-Q | 2020-05-05 |
| Quarterly | 2019-06-30 | 217483000.0 | +0.2% | shares | 10-Q | 2020-08-04 |
| Quarterly | 2019-09-30 | 217791000.0 | +0.1% | shares | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 216721000.0 | -0.5% | shares | 10-Q | 2021-05-04 |
| Quarterly | 2020-06-30 | 220434000.0 | +1.7% | shares | 10-Q | 2021-08-03 |
| Quarterly | 2020-09-30 | 218784000.0 | -0.7% | shares | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 221867000.0 | +1.4% | shares | 10-Q | 2022-05-03 |
| Quarterly | 2021-06-30 | 222250000.0 | +0.2% | shares | 10-Q | 2022-08-02 |
| Quarterly | 2021-09-30 | 222248000.0 | -0.0% | shares | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 222950000.0 | +0.3% | shares | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 223661000.0 | +0.3% | shares | 10-Q | 2023-08-01 |
| Quarterly | 2022-09-30 | 224175000.0 | +0.2% | shares | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 225589000.0 | +0.6% | shares | 10-Q | 2024-04-30 |
| Quarterly | 2023-06-30 | 225649000.0 | +0.0% | shares | 10-Q | 2024-07-30 |
| Quarterly | 2023-09-30 | 226167000.0 | +0.2% | shares | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 227219000.0 | +0.5% | shares | 10-Q | 2025-04-29 |
| Quarterly | 2024-06-30 | 218175000.0 | -4.0% | shares | 10-Q | 2025-07-29 |
| Quarterly | 2024-09-30 | 195838000.0 | -10.2% | shares | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 198197000.0 | +1.2% | shares | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 198744000.0 | +0.3% | shares | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 201429000.0 | +1.4% | shares | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 194125000.0 | — | shares | 10-K | 2019-02-14 |
| Annual | 2017-12-31 | 204580000.0 | +5.4% | shares | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 215635000.0 | +5.4% | shares | 10-K | 2021-02-09 |
| Annual | 2019-12-31 | 217657000.0 | +0.9% | shares | 10-K | 2022-02-08 |
| Annual | 2020-12-31 | 218073000.0 | +0.2% | shares | 10-K | 2023-02-07 |
| Annual | 2021-12-31 | 222074000.0 | +1.8% | shares | 10-K | 2024-02-13 |
| Annual | 2022-12-31 | 223958000.0 | +0.8% | shares | 10-K | 2025-02-10 |
| Annual | 2023-12-31 | 225928000.0 | +0.9% | shares | 10-K | 2026-02-10 |
| Annual | 2024-12-31 | 210530000.0 | -6.8% | shares | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 200700000.0 | -4.7% | shares | 10-K | 2026-02-10 |
Credit and Bond Coverage
Company-levelMetrics
Metrics: 8Asset Turnover
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.2387 | — | ratio | 10-Q | 2017-05-04 |
| Quarterly | 2016-06-30 | 0.1737 | -27.2% | ratio | 10-Q | 2017-08-01 |
| Quarterly | 2016-09-30 | 0.1745 | +0.5% | ratio | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | 0.2390 | +36.9% | ratio | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 0.1991 | -16.7% | ratio | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 0.1607 | -19.3% | ratio | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | 0.1658 | +3.2% | ratio | 10-Q | 2019-04-30 |
| Quarterly | 2018-06-30 | 0.2176 | +31.2% | ratio | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 0.1784 | -18.0% | ratio | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 0.1808 | +1.3% | ratio | 10-Q | 2020-05-05 |
| Quarterly | 2019-06-30 | 0.1798 | -0.5% | ratio | 10-Q | 2020-08-04 |
| Quarterly | 2019-09-30 | 0.1716 | -4.6% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 0.2065 | +20.4% | ratio | 10-Q | 2021-05-04 |
| Quarterly | 2020-06-30 | 0.2142 | +3.7% | ratio | 10-Q | 2021-08-03 |
| Quarterly | 2020-09-30 | 0.1877 | -12.4% | ratio | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 0.1652 | -12.0% | ratio | 10-Q | 2022-05-03 |
| Quarterly | 2021-06-30 | 0.1807 | +9.4% | ratio | 10-Q | 2022-08-02 |
| Quarterly | 2021-09-30 | 0.1936 | +7.1% | ratio | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 0.1451 | -25.1% | ratio | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 0.1713 | +18.1% | ratio | 10-Q | 2023-08-01 |
| Quarterly | 2022-09-30 | 0.1494 | -12.8% | ratio | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 0.1395 | -6.6% | ratio | 10-Q | 2024-04-30 |
| Quarterly | 2023-06-30 | 0.1538 | +10.2% | ratio | 10-Q | 2024-07-30 |
| Quarterly | 2023-09-30 | 0.1439 | -6.4% | ratio | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 0.1234 | -14.2% | ratio | 10-Q | 2025-04-29 |
| Quarterly | 2024-06-30 | 0.2239 | +81.4% | ratio | 10-Q | 2025-07-29 |
| Quarterly | 2024-09-30 | 0.2270 | +1.4% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 0.1831 | -19.3% | ratio | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 0.2088 | +14.0% | ratio | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 0.2158 | +3.3% | ratio | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 0.6748 | — | ratio | 10-K | 2019-02-14 |
| Annual | 2017-12-31 | 0.6672 | -1.1% | ratio | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 0.7113 | +6.6% | ratio | 10-K | 2021-02-09 |
| Annual | 2019-12-31 | 0.6300 | -11.4% | ratio | 10-K | 2022-02-08 |
| Annual | 2020-12-31 | 0.7489 | +18.9% | ratio | 10-K | 2023-02-07 |
| Annual | 2021-12-31 | 0.6053 | -19.2% | ratio | 10-K | 2024-02-13 |
| Annual | 2022-12-31 | 0.5812 | -4.0% | ratio | 10-K | 2025-02-10 |
| Annual | 2023-12-31 | 0.5449 | -6.2% | ratio | 10-K | 2026-02-10 |
| Annual | 2024-12-31 | 0.7790 | +43.0% | ratio | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 0.7389 | -5.1% | ratio | 10-K | 2026-02-10 |
Current Ratio
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 4.6705 | — | ratio | 10-Q | 2016-05-09 |
| Quarterly | 2016-06-30 | 3.9808 | -14.8% | ratio | 10-Q | 2016-08-09 |
| Quarterly | 2016-09-30 | 3.6860 | -7.4% | ratio | 10-Q | 2016-11-01 |
| Quarterly | 2016-12-31 | 3.6350 | -1.4% | ratio | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | 2.6883 | -26.0% | ratio | 10-Q | 2017-05-04 |
| Quarterly | 2017-06-30 | 2.8817 | +7.2% | ratio | 10-Q | 2017-08-01 |
| Quarterly | 2017-09-30 | 4.8176 | +67.2% | ratio | 10-Q | 2017-10-31 |
| Quarterly | 2017-12-31 | 4.0087 | -16.8% | ratio | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | 3.8564 | -3.8% | ratio | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 4.3398 | +12.5% | ratio | 10-Q | 2018-07-31 |
| Quarterly | 2018-09-30 | 4.0246 | -7.3% | ratio | 10-Q | 2018-10-30 |
| Quarterly | 2018-12-31 | 4.3084 | +7.1% | ratio | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 5.2248 | +21.3% | ratio | 10-Q | 2019-04-30 |
| Quarterly | 2019-06-30 | 5.6077 | +7.3% | ratio | 10-Q | 2019-07-30 |
| Quarterly | 2019-09-30 | 5.0242 | -10.4% | ratio | 10-Q | 2019-10-29 |
| Quarterly | 2019-12-31 | 4.8340 | -3.8% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 3.4091 | -29.5% | ratio | 10-Q | 2020-05-05 |
| Quarterly | 2020-06-30 | 3.7333 | +9.5% | ratio | 10-Q | 2020-08-04 |
| Quarterly | 2020-09-30 | 3.5622 | -4.6% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-12-31 | 3.7388 | +5.0% | ratio | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 3.9270 | +5.0% | ratio | 10-Q | 2021-05-04 |
| Quarterly | 2021-06-30 | 3.9678 | +1.0% | ratio | 10-Q | 2021-08-03 |
| Quarterly | 2021-09-30 | 3.9366 | -0.8% | ratio | 10-Q | 2021-11-02 |
| Quarterly | 2021-12-31 | 3.6505 | -7.3% | ratio | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 3.7105 | +1.6% | ratio | 10-Q | 2022-05-03 |
| Quarterly | 2022-06-30 | 3.9128 | +5.5% | ratio | 10-Q | 2022-08-02 |
| Quarterly | 2022-09-30 | 3.7961 | -3.0% | ratio | 10-Q | 2022-11-01 |
| Quarterly | 2022-12-31 | 3.5372 | -6.8% | ratio | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 3.9475 | +11.6% | ratio | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 3.8117 | -3.4% | ratio | 10-Q | 2023-08-01 |
| Quarterly | 2023-09-30 | 3.9146 | +2.7% | ratio | 10-Q | 2023-10-31 |
| Quarterly | 2023-12-31 | 3.7451 | -4.3% | ratio | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 3.4724 | -7.3% | ratio | 10-Q | 2024-04-30 |
| Quarterly | 2024-06-30 | 1.9200 | -44.7% | ratio | 10-Q | 2024-07-30 |
| Quarterly | 2024-09-30 | 1.8704 | -2.6% | ratio | 10-Q | 2024-10-29 |
| Quarterly | 2024-12-31 | 1.9728 | +5.5% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 2.0389 | +3.3% | ratio | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 2.8497 | +39.8% | ratio | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 3.1955 | +12.1% | ratio | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 3.6350 | — | ratio | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 4.0087 | +10.3% | ratio | 10-K | 2019-02-14 |
| Annual | 2018-12-31 | 4.3084 | +7.5% | ratio | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 4.8340 | +12.2% | ratio | 10-K | 2021-02-09 |
| Annual | 2020-12-31 | 3.7388 | -22.7% | ratio | 10-K | 2022-02-08 |
| Annual | 2021-12-31 | 3.6505 | -2.4% | ratio | 10-K | 2023-02-07 |
| Annual | 2022-12-31 | 3.5372 | -3.1% | ratio | 10-K | 2024-02-13 |
| Annual | 2023-12-31 | 3.7451 | +5.9% | ratio | 10-K | 2025-02-10 |
| Annual | 2024-12-31 | 1.9728 | -47.3% | ratio | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 3.3157 | +68.1% | ratio | 10-K | 2026-02-10 |
Debt to Equity
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 3.8472 | — | ratio | 10-Q | 2016-05-09 |
| Quarterly | 2016-06-30 | 3.7733 | -1.9% | ratio | 10-Q | 2016-08-09 |
| Quarterly | 2016-09-30 | 3.1737 | -15.9% | ratio | 10-Q | 2016-11-01 |
| Quarterly | 2016-12-31 | 2.9064 | -8.4% | ratio | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | 0.6640 | -77.2% | ratio | 10-Q | 2017-05-04 |
| Quarterly | 2017-06-30 | 0.5966 | -10.2% | ratio | 10-Q | 2017-08-01 |
| Quarterly | 2017-09-30 | 0.3508 | -41.2% | ratio | 10-Q | 2017-10-31 |
| Quarterly | 2017-12-31 | 0.4121 | +17.5% | ratio | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | 0.4164 | +1.1% | ratio | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 0.3833 | -8.0% | ratio | 10-Q | 2018-07-31 |
| Quarterly | 2018-09-30 | 0.3977 | +3.8% | ratio | 10-Q | 2018-10-30 |
| Quarterly | 2018-12-31 | 0.3737 | -6.0% | ratio | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 0.3206 | -14.2% | ratio | 10-Q | 2019-04-30 |
| Quarterly | 2019-06-30 | 0.3117 | -2.8% | ratio | 10-Q | 2019-07-30 |
| Quarterly | 2019-09-30 | 0.3271 | +4.9% | ratio | 10-Q | 2019-10-29 |
| Quarterly | 2019-12-31 | 0.3188 | -2.5% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 0.4204 | +31.9% | ratio | 10-Q | 2020-05-05 |
| Quarterly | 2020-06-30 | 0.3701 | -12.0% | ratio | 10-Q | 2020-08-04 |
| Quarterly | 2020-09-30 | 0.3834 | +3.6% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-12-31 | 0.3637 | -5.1% | ratio | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 0.3422 | -5.9% | ratio | 10-Q | 2021-05-04 |
| Quarterly | 2021-06-30 | 0.3300 | -3.6% | ratio | 10-Q | 2021-08-03 |
| Quarterly | 2021-09-30 | 0.3335 | +1.1% | ratio | 10-Q | 2021-11-02 |
| Quarterly | 2021-12-31 | 0.3086 | -7.5% | ratio | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 0.3083 | -0.1% | ratio | 10-Q | 2022-05-03 |
| Quarterly | 2022-06-30 | 0.3021 | -2.0% | ratio | 10-Q | 2022-08-02 |
| Quarterly | 2022-09-30 | 0.3037 | +0.5% | ratio | 10-Q | 2022-11-01 |
| Quarterly | 2022-12-31 | 0.3366 | +10.8% | ratio | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 0.2992 | -11.1% | ratio | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 0.3096 | +3.5% | ratio | 10-Q | 2023-08-01 |
| Quarterly | 2023-09-30 | 0.2954 | -4.6% | ratio | 10-Q | 2023-10-31 |
| Quarterly | 2023-12-31 | 0.3068 | +3.9% | ratio | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 0.3228 | +5.2% | ratio | 10-Q | 2024-04-30 |
| Quarterly | 2024-06-30 | 0.5555 | +72.1% | ratio | 10-Q | 2024-07-30 |
| Quarterly | 2024-09-30 | 0.5806 | +4.5% | ratio | 10-Q | 2024-10-29 |
| Quarterly | 2024-12-31 | 0.5792 | -0.2% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 0.5676 | -2.0% | ratio | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 0.3957 | -30.3% | ratio | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 0.3610 | -8.8% | ratio | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 2.9064 | — | ratio | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 0.4121 | -85.8% | ratio | 10-K | 2019-02-14 |
| Annual | 2018-12-31 | 0.3737 | -9.3% | ratio | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 0.3188 | -14.7% | ratio | 10-K | 2021-02-09 |
| Annual | 2020-12-31 | 0.3637 | +14.1% | ratio | 10-K | 2022-02-08 |
| Annual | 2021-12-31 | 0.3086 | -15.1% | ratio | 10-K | 2023-02-07 |
| Annual | 2022-12-31 | 0.3366 | +9.1% | ratio | 10-K | 2024-02-13 |
| Annual | 2023-12-31 | 0.3068 | -8.8% | ratio | 10-K | 2025-02-10 |
| Annual | 2024-12-31 | 0.5792 | +88.8% | ratio | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 0.3465 | -40.2% | ratio | 10-K | 2026-02-10 |
Net Margin
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2017-03-31 | -0.4871 | — | ratio | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | -0.6113 | -25.5% | ratio | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | -0.4286 | +29.9% | ratio | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | -0.1076 | +74.9% | ratio | 10-Q | 2019-10-29 |
| Quarterly | 2018-06-30 | 0.1005 | +193.4% | ratio | 10-Q | 2019-10-29 |
| Quarterly | 2018-09-30 | 0.0899 | -10.5% | ratio | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 0.2055 | +128.6% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2019-06-30 | 0.1987 | -3.3% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2019-09-30 | 0.6090 | +206.4% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | -1.2676 | -308.2% | ratio | 10-Q | 2021-11-02 |
| Quarterly | 2020-06-30 | 0.4219 | +133.3% | ratio | 10-Q | 2021-11-02 |
| Quarterly | 2020-09-30 | -0.7179 | -270.1% | ratio | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 0.0885 | +112.3% | ratio | 10-Q | 2022-11-01 |
| Quarterly | 2021-06-30 | 0.2118 | +139.2% | ratio | 10-Q | 2022-11-01 |
| Quarterly | 2021-09-30 | 0.4732 | +123.5% | ratio | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 0.0518 | -89.1% | ratio | 10-Q | 2023-10-31 |
| Quarterly | 2022-06-30 | 0.1771 | +241.8% | ratio | 10-Q | 2023-10-31 |
| Quarterly | 2022-09-30 | 0.3792 | +114.1% | ratio | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 0.0268 | -92.9% | ratio | 10-Q | 2024-10-29 |
| Quarterly | 2023-06-30 | 0.2132 | +694.5% | ratio | 10-Q | 2024-10-29 |
| Quarterly | 2023-09-30 | 0.4315 | +102.3% | ratio | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 0.1925 | -55.4% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2024-06-30 | -0.4260 | -321.3% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2024-09-30 | -0.1482 | +65.2% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 0.1503 | +201.4% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2025-06-30 | 0.3332 | +121.7% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2025-09-30 | 0.7228 | +116.9% | ratio | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 0.0943 | — | ratio | 10-K | 2019-02-14 |
| Annual | 2017-12-31 | -0.2038 | -316.3% | ratio | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 0.0582 | +128.5% | ratio | 10-K | 2021-02-09 |
| Annual | 2019-12-31 | 0.2070 | +255.8% | ratio | 10-K | 2022-02-08 |
| Annual | 2020-12-31 | -0.1109 | -153.6% | ratio | 10-K | 2023-02-07 |
| Annual | 2021-12-31 | 0.3176 | +386.5% | ratio | 10-K | 2024-02-13 |
| Annual | 2022-12-31 | 0.1004 | -68.4% | ratio | 10-K | 2025-02-10 |
| Annual | 2023-12-31 | 0.1617 | +61.1% | ratio | 10-K | 2026-02-10 |
| Annual | 2024-12-31 | 0.0077 | -95.2% | ratio | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 0.2503 | +3154.4% | ratio | 10-K | 2026-02-10 |
Operating Margin
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 0.1368 | — | ratio | 10-Q | 2017-05-04 |
| Quarterly | 2016-06-30 | 0.1810 | +32.4% | ratio | 10-Q | 2017-08-01 |
| Quarterly | 2016-09-30 | 0.0827 | -54.3% | ratio | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | -0.3469 | -519.4% | ratio | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | 0.0222 | +106.4% | ratio | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | 0.0394 | +77.0% | ratio | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | -0.1756 | -546.0% | ratio | 10-Q | 2019-04-30 |
| Quarterly | 2018-06-30 | 0.1596 | +190.9% | ratio | 10-Q | 2019-07-30 |
| Quarterly | 2018-09-30 | 0.0692 | -56.6% | ratio | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 0.1488 | +115.0% | ratio | 10-Q | 2020-05-05 |
| Quarterly | 2019-06-30 | 0.1861 | +25.1% | ratio | 10-Q | 2020-08-04 |
| Quarterly | 2019-09-30 | 0.2435 | +30.9% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | -1.1680 | -579.6% | ratio | 10-Q | 2021-05-04 |
| Quarterly | 2020-06-30 | 0.3354 | +128.7% | ratio | 10-Q | 2021-08-03 |
| Quarterly | 2020-09-30 | 0.0086 | -97.4% | ratio | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 0.1634 | +1803.8% | ratio | 10-Q | 2022-05-03 |
| Quarterly | 2021-06-30 | 0.1996 | +22.2% | ratio | 10-Q | 2022-08-02 |
| Quarterly | 2021-09-30 | 0.2896 | +45.1% | ratio | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 0.1589 | -45.1% | ratio | 10-Q | 2023-05-02 |
| Quarterly | 2022-06-30 | 0.2792 | +75.6% | ratio | 10-Q | 2023-08-01 |
| Quarterly | 2022-09-30 | 0.1681 | -39.8% | ratio | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 0.0306 | -81.8% | ratio | 10-Q | 2024-04-30 |
| Quarterly | 2023-06-30 | 0.2030 | +562.7% | ratio | 10-Q | 2024-07-30 |
| Quarterly | 2023-09-30 | 0.2336 | +15.1% | ratio | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 0.1043 | -55.3% | ratio | 10-Q | 2025-04-29 |
| Quarterly | 2024-06-30 | -0.4581 | -539.1% | ratio | 10-Q | 2025-07-29 |
| Quarterly | 2024-09-30 | 0.1284 | +128.0% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 0.1949 | +51.8% | ratio | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 0.4363 | +123.9% | ratio | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 0.3247 | -25.6% | ratio | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 0.1311 | — | ratio | 10-K | 2019-02-14 |
| Annual | 2017-12-31 | -0.1584 | -220.8% | ratio | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 0.0687 | +143.3% | ratio | 10-K | 2021-02-09 |
| Annual | 2019-12-31 | 0.1862 | +171.2% | ratio | 10-K | 2022-02-08 |
| Annual | 2020-12-31 | -0.0989 | -153.1% | ratio | 10-K | 2023-02-07 |
| Annual | 2021-12-31 | 0.1962 | +298.4% | ratio | 10-K | 2024-02-13 |
| Annual | 2022-12-31 | 0.1707 | -13.0% | ratio | 10-K | 2025-02-10 |
| Annual | 2023-12-31 | 0.1679 | -1.6% | ratio | 10-K | 2026-02-10 |
| Annual | 2024-12-31 | 0.0145 | -91.4% | ratio | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 0.2946 | +1936.4% | ratio | 10-K | 2026-02-10 |
Quick Ratio
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2016-03-31 | 3.2828 | — | ratio | 10-Q | 2017-05-04 |
| Quarterly | 2016-06-30 | 2.4507 | -25.3% | ratio | 10-Q | 2017-08-01 |
| Quarterly | 2016-09-30 | 2.4116 | -1.6% | ratio | 10-Q | 2017-10-31 |
| Quarterly | 2016-12-31 | 2.3852 | -1.1% | ratio | 10-Q | 2017-10-31 |
| Quarterly | 2017-03-31 | 1.1874 | -50.2% | ratio | 10-Q | 2017-05-04 |
| Quarterly | 2017-06-30 | 1.5410 | +29.8% | ratio | 10-Q | 2017-08-01 |
| Quarterly | 2017-09-30 | 3.5259 | +128.8% | ratio | 10-Q | 2017-10-31 |
| Quarterly | 2017-12-31 | 2.3962 | -32.0% | ratio | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | 2.3471 | -2.0% | ratio | 10-Q | 2018-05-01 |
| Quarterly | 2018-06-30 | 2.5215 | +7.4% | ratio | 10-Q | 2018-07-31 |
| Quarterly | 2018-09-30 | 2.6324 | +4.4% | ratio | 10-Q | 2018-10-30 |
| Quarterly | 2018-12-31 | 2.7370 | +4.0% | ratio | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 3.5656 | +30.3% | ratio | 10-Q | 2019-04-30 |
| Quarterly | 2019-06-30 | 3.8578 | +8.2% | ratio | 10-Q | 2019-07-30 |
| Quarterly | 2019-09-30 | 3.6866 | -4.4% | ratio | 10-Q | 2019-10-29 |
| Quarterly | 2019-12-31 | 3.5701 | -3.2% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | 2.0723 | -42.0% | ratio | 10-Q | 2020-05-05 |
| Quarterly | 2020-06-30 | 2.3840 | +15.0% | ratio | 10-Q | 2020-08-04 |
| Quarterly | 2020-09-30 | 2.4708 | +3.6% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-12-31 | 2.3971 | -3.0% | ratio | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 2.6767 | +11.7% | ratio | 10-Q | 2021-05-04 |
| Quarterly | 2021-06-30 | 2.7223 | +1.7% | ratio | 10-Q | 2021-08-03 |
| Quarterly | 2021-09-30 | 2.6915 | -1.1% | ratio | 10-Q | 2021-11-02 |
| Quarterly | 2021-12-31 | 2.4083 | -10.5% | ratio | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 2.5467 | +5.7% | ratio | 10-Q | 2022-05-03 |
| Quarterly | 2022-06-30 | 2.6281 | +3.2% | ratio | 10-Q | 2022-08-02 |
| Quarterly | 2022-09-30 | 2.6730 | +1.7% | ratio | 10-Q | 2022-11-01 |
| Quarterly | 2022-12-31 | 2.5508 | -4.6% | ratio | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 2.8039 | +9.9% | ratio | 10-Q | 2023-05-02 |
| Quarterly | 2023-06-30 | 2.7987 | -0.2% | ratio | 10-Q | 2023-08-01 |
| Quarterly | 2023-09-30 | 2.8695 | +2.5% | ratio | 10-Q | 2023-10-31 |
| Quarterly | 2023-12-31 | 2.5906 | -9.7% | ratio | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 2.3962 | -7.5% | ratio | 10-Q | 2024-04-30 |
| Quarterly | 2024-06-30 | 0.7384 | -69.2% | ratio | 10-Q | 2024-07-30 |
| Quarterly | 2024-09-30 | 0.8685 | +17.6% | ratio | 10-Q | 2024-10-29 |
| Quarterly | 2024-12-31 | 1.0280 | +18.4% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 1.1287 | +9.8% | ratio | 10-Q | 2025-04-29 |
| Quarterly | 2025-06-30 | 1.5290 | +35.5% | ratio | 10-Q | 2025-07-29 |
| Quarterly | 2025-09-30 | 1.8338 | +19.9% | ratio | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 2.3852 | — | ratio | 10-K | 2018-02-15 |
| Annual | 2017-12-31 | 2.3962 | +0.5% | ratio | 10-K | 2019-02-14 |
| Annual | 2018-12-31 | 2.7370 | +14.2% | ratio | 10-K | 2020-02-13 |
| Annual | 2019-12-31 | 3.5701 | +30.4% | ratio | 10-K | 2021-02-09 |
| Annual | 2020-12-31 | 2.3971 | -32.9% | ratio | 10-K | 2022-02-08 |
| Annual | 2021-12-31 | 2.4083 | +0.5% | ratio | 10-K | 2023-02-07 |
| Annual | 2022-12-31 | 2.5508 | +5.9% | ratio | 10-K | 2024-02-13 |
| Annual | 2023-12-31 | 2.5906 | +1.6% | ratio | 10-K | 2025-02-10 |
| Annual | 2024-12-31 | 1.0280 | -60.3% | ratio | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 2.0445 | +98.9% | ratio | 10-K | 2026-02-10 |
ROA
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2017-03-31 | -0.1164 | — | ratio | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | -0.1217 | -4.6% | ratio | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | -0.0689 | +43.4% | ratio | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | -0.0178 | +74.1% | ratio | 10-Q | 2019-10-29 |
| Quarterly | 2018-06-30 | 0.0219 | +222.5% | ratio | 10-Q | 2019-10-29 |
| Quarterly | 2018-09-30 | 0.0160 | -26.6% | ratio | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 0.0371 | +131.5% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2019-06-30 | 0.0357 | -3.8% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2019-09-30 | 0.1045 | +192.4% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | -0.2618 | -350.6% | ratio | 10-Q | 2021-11-02 |
| Quarterly | 2020-06-30 | 0.0904 | +134.5% | ratio | 10-Q | 2021-11-02 |
| Quarterly | 2020-09-30 | -0.1347 | -249.1% | ratio | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 0.0146 | +110.9% | ratio | 10-Q | 2022-11-01 |
| Quarterly | 2021-06-30 | 0.0383 | +161.8% | ratio | 10-Q | 2022-11-01 |
| Quarterly | 2021-09-30 | 0.0916 | +139.4% | ratio | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 0.0075 | -91.8% | ratio | 10-Q | 2023-10-31 |
| Quarterly | 2022-06-30 | 0.0303 | +303.8% | ratio | 10-Q | 2023-10-31 |
| Quarterly | 2022-09-30 | 0.0567 | +86.7% | ratio | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 0.0037 | -93.4% | ratio | 10-Q | 2024-10-29 |
| Quarterly | 2023-06-30 | 0.0328 | +775.8% | ratio | 10-Q | 2024-10-29 |
| Quarterly | 2023-09-30 | 0.0621 | +89.3% | ratio | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 0.0238 | -61.7% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2024-06-30 | -0.0954 | -501.4% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2024-09-30 | -0.0336 | +64.7% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 0.0275 | +181.8% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2025-06-30 | 0.0696 | +152.8% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2025-09-30 | 0.1560 | +124.2% | ratio | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 0.0636 | — | ratio | 10-K | 2019-02-14 |
| Annual | 2017-12-31 | -0.1360 | -313.8% | ratio | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 0.0414 | +130.4% | ratio | 10-K | 2021-02-09 |
| Annual | 2019-12-31 | 0.1304 | +215.1% | ratio | 10-K | 2022-02-08 |
| Annual | 2020-12-31 | -0.0830 | -163.7% | ratio | 10-K | 2023-02-07 |
| Annual | 2021-12-31 | 0.1923 | +331.6% | ratio | 10-K | 2024-02-13 |
| Annual | 2022-12-31 | 0.0583 | -69.7% | ratio | 10-K | 2025-02-10 |
| Annual | 2023-12-31 | 0.0881 | +51.1% | ratio | 10-K | 2026-02-10 |
| Annual | 2024-12-31 | 0.0060 | -93.2% | ratio | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 0.1849 | +2986.8% | ratio | 10-K | 2026-02-10 |
ROE
Quarterly
Annual
Show Data Rows
| Frequency | Period End | Value | % Chg | Unit | Form | Filed |
|---|---|---|---|---|---|---|
| Quarterly | 2017-03-31 | -0.1937 | — | ratio | 10-Q | 2018-05-01 |
| Quarterly | 2017-06-30 | -0.1944 | -0.3% | ratio | 10-Q | 2018-07-31 |
| Quarterly | 2017-09-30 | -0.0930 | +52.1% | ratio | 10-Q | 2018-10-30 |
| Quarterly | 2018-03-31 | -0.0253 | +72.8% | ratio | 10-Q | 2019-10-29 |
| Quarterly | 2018-06-30 | 0.0302 | +219.6% | ratio | 10-Q | 2019-10-29 |
| Quarterly | 2018-09-30 | 0.0224 | -25.8% | ratio | 10-Q | 2019-10-29 |
| Quarterly | 2019-03-31 | 0.0491 | +118.8% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2019-06-30 | 0.0469 | -4.5% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2019-09-30 | 0.1387 | +195.9% | ratio | 10-Q | 2020-11-05 |
| Quarterly | 2020-03-31 | -0.3719 | -368.2% | ratio | 10-Q | 2021-11-02 |
| Quarterly | 2020-06-30 | 0.1238 | +133.3% | ratio | 10-Q | 2021-11-02 |
| Quarterly | 2020-09-30 | -0.1864 | -250.5% | ratio | 10-Q | 2021-11-02 |
| Quarterly | 2021-03-31 | 0.0196 | +110.5% | ratio | 10-Q | 2022-11-01 |
| Quarterly | 2021-06-30 | 0.0509 | +159.4% | ratio | 10-Q | 2022-11-01 |
| Quarterly | 2021-09-30 | 0.1222 | +140.0% | ratio | 10-Q | 2022-11-01 |
| Quarterly | 2022-03-31 | 0.0098 | -92.0% | ratio | 10-Q | 2023-10-31 |
| Quarterly | 2022-06-30 | 0.0395 | +301.8% | ratio | 10-Q | 2023-10-31 |
| Quarterly | 2022-09-30 | 0.0739 | +86.9% | ratio | 10-Q | 2023-10-31 |
| Quarterly | 2023-03-31 | 0.0049 | -93.4% | ratio | 10-Q | 2024-10-29 |
| Quarterly | 2023-06-30 | 0.0429 | +782.9% | ratio | 10-Q | 2024-10-29 |
| Quarterly | 2023-09-30 | 0.0804 | +87.3% | ratio | 10-Q | 2024-10-29 |
| Quarterly | 2024-03-31 | 0.0314 | -60.9% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2024-06-30 | -0.1483 | -572.0% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2024-09-30 | -0.0532 | +64.2% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2025-03-31 | 0.0431 | +181.1% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2025-06-30 | 0.0971 | +125.1% | ratio | 10-Q | 2025-10-28 |
| Quarterly | 2025-09-30 | 0.2123 | +118.6% | ratio | 10-Q | 2025-10-28 |
| Annual | 2016-12-31 | 0.2485 | — | ratio | 10-K | 2019-02-14 |
| Annual | 2017-12-31 | -0.1920 | -177.3% | ratio | 10-K | 2020-02-13 |
| Annual | 2018-12-31 | 0.0569 | +129.6% | ratio | 10-K | 2021-02-09 |
| Annual | 2019-12-31 | 0.1720 | +202.5% | ratio | 10-K | 2022-02-08 |
| Annual | 2020-12-31 | -0.1132 | -165.8% | ratio | 10-K | 2023-02-07 |
| Annual | 2021-12-31 | 0.2516 | +322.2% | ratio | 10-K | 2024-02-13 |
| Annual | 2022-12-31 | 0.0780 | -69.0% | ratio | 10-K | 2025-02-10 |
| Annual | 2023-12-31 | 0.1151 | +47.7% | ratio | 10-K | 2026-02-10 |
| Annual | 2024-12-31 | 0.0095 | -91.8% | ratio | 10-K | 2026-02-10 |
| Annual | 2025-12-31 | 0.2490 | +2532.0% | ratio | 10-K | 2026-02-10 |
8-K Material Event Details
This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.
Event Type Distribution
Count per 8-K itemInsider Transaction History
Net Insider Flow
Monthly open-market buy value minus open-market sell valueMonthly Insider Activity Mix
Share volume split between open-market trades, grants, and exercisesTransaction Value Timeline
All Transactions
| Date | Insider | Title | Type | Security | Shares | Price | Total Value | Post-Tx Shares |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | BAKER BROS. ADVISORS LP | — |
Equity grant / award
A
|
Common Stock | 421 | $0.00 | $0 | 28,188,718 |
| 2026-03-25 | Trotta Matteo | EVP, GM, Dermatology US |
Other disposed transaction
F
|
Common Stock | 537 | $92.23 | $49,528 | 14,882 |
| 2026-03-17 | CAGNONI PABLO J | President, R&D |
Exercise / conversion
M · derivative
|
Employee Stock Option (right to buy) | 11,501 | $0.00 | $0 | 32,910 |
| 2026-03-17 | CAGNONI PABLO J | President, R&D |
Exercise / conversion
M · derivative
|
Employee Stock Option (right to buy) | 7,166 | $0.00 | $0 | 9,102 |
| 2026-03-17 | CAGNONI PABLO J | President, R&D |
Open-market sell
S
|
Common Stock | 18,667 | $94.24 | $1,759,178 | 234,800 |
| 2026-03-17 | CAGNONI PABLO J | President, R&D |
Exercise / conversion
M
|
Common Stock | 11,501 | $64.25 | $738,939 | 253,467 |
| 2026-03-17 | CAGNONI PABLO J | President, R&D |
Exercise / conversion
M
|
Common Stock | 7,166 | $61.18 | $438,416 | 241,966 |
| 2026-02-19 | CAGNONI PABLO J | President, R&D |
Exercise / conversion
M · derivative
|
Employee Stock Option (right to buy) | 5,575 | $0.00 | $0 | 16,268 |
| 2026-02-19 | CAGNONI PABLO J | President, R&D |
Exercise / conversion
M · derivative
|
Employee Stock Option (right to buy) | 13,093 | $0.00 | $0 | 7,182 |
| 2026-02-19 | CAGNONI PABLO J | President, R&D |
Open-market sell
S
|
Common Stock | 18,668 | $100.91 | $1,883,788 | 234,800 |
| 2026-02-19 | CAGNONI PABLO J | President, R&D |
Exercise / conversion
M
|
Common Stock | 5,575 | $61.18 | $341,078 | 253,468 |
| 2026-02-19 | CAGNONI PABLO J | President, R&D |
Exercise / conversion
M
|
Common Stock | 13,093 | $61.76 | $808,624 | 247,893 |
| 2026-02-02 | Morrissey Michael James | EVP, Head of Tech. Operations |
Other disposed transaction
F
|
Common Stock | 185 | $102.67 | $18,994 | 34,065 |
| 2026-01-16 | Heeson Lee | EVP, Head of Incyte Intl |
Equity grant / award
A
|
Common Stock | 8,911 | $0.00 | $0 | 38,152 |
| 2026-01-07 | Issa Mohamed Khairie | EVP, Head of US Oncology |
Open-market sell
S
|
Common Stock | 10,856 | $109.07 | $1,184,064 | 66,132 |
| 2026-01-06 | Issa Mohamed Khairie | EVP, Head of US Oncology |
Other disposed transaction
F
|
Common Stock | 8,264 | $106.66 | $881,438 | 76,988 |
| 2026-01-05 | Stein Steven H | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 15,634 | $101.70 | $1,589,978 | 34,203 |
| 2025-12-31 | Clancy Paul J | Dir |
Equity grant / award
A
|
Common Stock | 241 | $98.77 | $23,804 | 23,476 |
| 2025-12-19 | Tray Thomas | Principal Accounting Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,730 | $0.00 | $0 | 0 |
| 2025-12-19 | Tray Thomas | Principal Accounting Officer |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 1,044 | $0.00 | $0 | 0 |
| 2025-12-19 | Tray Thomas | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 2,774 | $100.00 | $277,400 | 22,973 |
| 2025-12-19 | Tray Thomas | Principal Accounting Officer |
Exercise / conversion
M
|
Common Stock | 1,730 | $95.76 | $165,665 | 25,747 |
| 2025-12-19 | Tray Thomas | Principal Accounting Officer |
Exercise / conversion
M
|
Common Stock | 1,044 | $95.76 | $99,973 | 24,017 |
| 2025-12-18 | Tray Thomas | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 600 | $98.25 | $58,950 | 22,973 |
| 2025-12-17 | Morrissey Michael James | EVP, Head of Tech. Operations |
Open-market sell
S
|
Common Stock | 4,323 | $97.26 | $420,455 | 27,507 |
| 2025-12-16 | Morrissey Michael James | EVP, Head of Tech. Operations |
Open-market sell
S
|
Common Stock | 53,175 | $97.29 | $5,173,396 | 31,830 |
| 2025-12-16 | Morrissey Michael James | EVP, Head of Tech. Operations |
Open-market sell
S
|
Common Stock | 833 | $97.42 | $81,151 | 85,005 |
| 2025-12-11 | Mayes Patrick A | EVP & Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 255 | $94.94 | $24,210 | 60,011 |
| 2025-12-10 | Mayes Patrick A | EVP & Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 5,553 | $95.58 | $530,756 | 60,266 |
| 2025-12-08 | Hoppenot Herve | Dir |
Other disposed transaction
F
|
Common Stock | 2,843 | $96.70 | $274,918 | 326,803 |
| 2025-12-02 | Stein Steven H | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 20,105 | $102.51 | $2,060,964 | 63,129 |
| 2025-12-01 | Stein Steven H | EVP & Chief Medical Officer |
Other disposed transaction
F
|
Common Stock | 17,093 | $102.04 | $1,744,170 | 83,234 |
| 2025-12-01 | Stein Steven H | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 2,559 | $102.96 | $263,475 | 100,327 |
| 2025-11-24 | Tray Thomas | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 600 | $103.00 | $61,800 | 23,573 |
| 2025-11-21 | Tray Thomas | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 169 | $102.00 | $17,238 | 24,173 |
| 2025-11-17 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Employee Stock Option (right to buy) | 278 | $0.00 | $0 | 8,883 |
| 2025-11-17 | Denton Sheila A. | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 278 | $104.36 | $29,012 | 26,569 |
| 2025-11-17 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 278 | $64.25 | $17,862 | 26,847 |
| 2025-11-10 | Hoppenot Herve | Dir |
Open-market sell
S
|
Common Stock | 187,500 | $105.46 | $19,773,750 | 329,646 |
| 2025-11-05 | Stein Steven H | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 1,044 | $0.00 | $0 | 0 |
| 2025-11-05 | Stein Steven H | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,995 | $0.00 | $0 | 0 |
| 2025-11-05 | Stein Steven H | EVP & Chief Medical Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,194 | $0.00 | $0 | 0 |
| 2025-11-05 | Stein Steven H | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 5,233 | $102.20 | $534,813 | 102,886 |
| 2025-11-05 | Stein Steven H | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 1,044 | $95.76 | $99,973 | 108,119 |
| 2025-11-05 | Stein Steven H | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 2,995 | $95.76 | $286,801 | 107,075 |
| 2025-11-05 | Stein Steven H | EVP & Chief Medical Officer |
Exercise / conversion
M
|
Common Stock | 1,194 | $83.83 | $100,093 | 104,080 |
| 2025-11-04 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Employee Stock Option (right to buy) | 598 | $0.00 | $0 | 13,765 |
| 2025-11-04 | Denton Sheila A. | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 598 | $101.36 | $60,613 | 26,569 |
| 2025-11-04 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 598 | $58.06 | $34,720 | 27,167 |
| 2025-11-03 | Heeson Lee | EVP, Head of Incyte Intl |
Open-market sell
S
|
Common Stock | 3,074 | $94.02 | $289,017 | 29,241 |
| 2025-10-15 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Employee Stock Option (right to buy) | 277 | $0.00 | $0 | 9,161 |
| 2025-10-15 | Denton Sheila A. | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 277 | $85.13 | $23,581 | 26,569 |
| 2025-10-15 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 277 | $64.25 | $17,797 | 26,846 |
| 2025-10-03 | Denton Sheila A. | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 3,501 | $85.54 | $299,476 | 26,569 |
| 2025-10-02 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Employee Stock Option (right to buy) | 599 | $0.00 | $0 | 14,363 |
| 2025-10-02 | Denton Sheila A. | EVP & General Counsel |
Other disposed transaction
F
|
Common Stock | 3,130 | $86.28 | $270,056 | 30,070 |
| 2025-10-02 | Denton Sheila A. | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 599 | $87.65 | $52,502 | 33,200 |
| 2025-10-02 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 599 | $58.06 | $34,778 | 33,799 |
| 2025-10-01 | Mayes Patrick A | EVP & Chief Scientific Officer |
Other disposed transaction
F
|
Common Stock | 1,569 | $86.70 | $136,032 | 65,819 |
| 2025-09-30 | BAKER BROS. ADVISORS LP | — |
Equity grant / award
A
|
Common Stock | 388 | $0.00 | $0 | 28,187,969 |
| 2025-09-22 | Gardner David H | EVP, Chief Strategy Officer |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 42,899 | $0.00 | $0 | 42,899 |
| 2025-09-22 | Gardner David H | EVP, Chief Strategy Officer |
Equity grant / award
A · derivative
|
Performance Shares | 23,573 | $0.00 | $0 | 23,573 |
| 2025-09-22 | Gardner David H | EVP, Chief Strategy Officer |
Equity grant / award
A
|
Common Stock | 9,429 | $0.00 | $0 | 9,429 |
| 2025-09-16 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Employee Stock Option (right to buy) | 278 | $0.00 | $0 | 9,438 |
| 2025-09-16 | Denton Sheila A. | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 278 | $83.15 | $23,116 | 33,200 |
| 2025-09-16 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 278 | $64.25 | $17,862 | 33,478 |
| 2025-09-02 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Employee Stock Option (right to buy) | 598 | $0.00 | $0 | 14,962 |
| 2025-09-02 | Denton Sheila A. | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 598 | $84.97 | $50,812 | 33,200 |
| 2025-09-02 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 598 | $58.06 | $34,720 | 33,798 |
| 2025-08-25 | Basi Ramitpal K | EVP, Human Resources |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 29,230 | $0.00 | $0 | 29,230 |
| 2025-08-25 | Basi Ramitpal K | EVP, Human Resources |
Equity grant / award
A · derivative
|
Performance Shares | 16,265 | $0.00 | $0 | 16,265 |
| 2025-08-25 | Basi Ramitpal K | EVP, Human Resources |
Equity grant / award
A
|
Common Stock | 6,506 | $0.00 | $0 | 6,506 |
| 2025-08-15 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Employee Stock Option (right to buy) | 277 | $0.00 | $0 | 9,716 |
| 2025-08-15 | Denton Sheila A. | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 277 | $86.81 | $24,046 | 33,200 |
| 2025-08-15 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 277 | $64.25 | $17,797 | 33,477 |
| 2025-08-04 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Employee Stock Option (right to buy) | 598 | $0.00 | $0 | 15,560 |
| 2025-08-04 | Denton Sheila A. | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 598 | $75.77 | $45,310 | 33,200 |
| 2025-08-04 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 598 | $58.06 | $34,720 | 33,798 |
| 2025-07-21 | Stein Steven H | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 3,706 | $67.94 | $251,786 | 102,886 |
| 2025-07-16 | Denton Sheila A. | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 785 | $68.36 | $53,663 | 33,200 |
| 2025-07-16 | Flannelly Barry P | EVP & General Manager US |
Open-market sell
S
|
Common Stock | 1,340 | $68.36 | $91,602 | 35,149 |
| 2025-07-15 | CAGNONI PABLO J | President, R&D |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 39,471 | $0.00 | $0 | 39,471 |
| 2025-07-15 | CAGNONI PABLO J | President, R&D |
Equity grant / award
A · derivative
|
Performance Shares | 43,846 | $0.00 | $0 | 43,846 |
| 2025-07-15 | CAGNONI PABLO J | President, R&D |
Equity grant / award
A
|
Common Stock | 17,538 | $0.00 | $0 | 234,800 |
| 2025-07-15 | CAGNONI PABLO J | President, R&D |
Other disposed transaction
F
|
Common Stock | 2,628 | $68.25 | $179,361 | 217,262 |
| 2025-07-15 | Denton Sheila A. | EVP & General Counsel |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 18,419 | $0.00 | $0 | 18,419 |
| 2025-07-15 | Denton Sheila A. | EVP & General Counsel |
Equity grant / award
A · derivative
|
Performance Shares | 20,461 | $0.00 | $0 | 20,461 |
| 2025-07-15 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Employee Stock Option (right to buy) | 3,330 | $0.00 | $0 | 9,993 |
| 2025-07-15 | Denton Sheila A. | EVP & General Counsel |
Equity grant / award
A
|
Common Stock | 8,184 | $0.00 | $0 | 33,985 |
| 2025-07-15 | Denton Sheila A. | EVP & General Counsel |
Other disposed transaction
F
|
Common Stock | 703 | $68.25 | $47,980 | 25,801 |
| 2025-07-15 | Denton Sheila A. | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 3,330 | $69.86 | $232,634 | 26,504 |
| 2025-07-15 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 3,330 | $64.25 | $213,952 | 29,834 |
| 2025-07-14 | CAGNONI PABLO J | President, R&D |
Other disposed transaction
F
|
Common Stock | 1,280 | $69.98 | $89,574 | 219,890 |
| 2025-07-02 | SWAIN PAULA J | EVP, Human Resources |
Other disposed transaction
F
|
Common Stock | 6,285 | $68.17 | $428,448 | 101,059 |
| 2025-06-30 | BAKER BROS. ADVISORS LP | — |
Equity grant / award
A
|
Common Stock | 492 | $0.00 | $0 | 28,187,581 |
| 2025-06-26 | Meury William | Chief Executive Officer |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 110,630 | $0.00 | $0 | 110,630 |
| 2025-06-10 | BRAWLEY OTIS W | Dir |
Equity grant / award
A · derivative
|
Non Qualfied Stock Option (right to buy) | 9,216 | $0.00 | $0 | 9,216 |
| 2025-06-10 | BRAWLEY OTIS W | Dir |
Equity grant / award
A
|
Common Stock | 2,518 | $0.00 | $0 | 11,252 |
| 2025-06-03 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Employee Stock Option (right to buy) | 1,795 | $0.00 | $0 | 16,757 |
| 2025-06-03 | Denton Sheila A. | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 1,795 | $68.00 | $122,060 | 26,504 |
| 2025-06-03 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 1,795 | $58.06 | $104,218 | 28,299 |
| 2025-06-02 | Tray Thomas | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 651 | $64.88 | $42,237 | 22,003 |
| 2025-05-30 | Tray Thomas | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 963 | $65.71 | $63,279 | 22,654 |
| 2025-04-01 | Flannelly Barry P | EVP & General Manager US |
Equity grant / award
A
|
Common Stock | 14,976 | $0.00 | $0 | 59,702 |
| 2025-04-01 | Flannelly Barry P | EVP & General Manager US |
Equity grant / award
A
|
Common Stock | 11,159 | $0.00 | $0 | 44,726 |
| 2025-03-31 | BAKER BROS. ADVISORS LP | — |
Equity grant / award
A
|
Common Stock | 487 | $0.00 | $0 | 28,184,571 |
| 2025-03-25 | Trotta Matteo | EVP, GM, Dermatology US |
Other disposed transaction
F
|
Common Stock | 537 | $62.08 | $33,337 | 9,937 |
| 2025-03-14 | Flannelly Barry P | EVP & General Manager US |
Open-market sell
S
|
Common Stock | 19,147 | $67.68 | $1,295,869 | 33,567 |
| 2025-03-14 | Flannelly Barry P | EVP & General Manager US |
Open-market sell
S
|
Common Stock | 199 | $67.88 | $13,508 | 52,714 |
| 2025-03-14 | Flannelly Barry P | EVP & General Manager US |
Open-market sell
S
|
Common Stock | 461 | $67.85 | $31,279 | 52,913 |
| 2025-03-04 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Employee Stock Option (right to buy) | 599 | $0.00 | $0 | 18,552 |
| 2025-03-04 | Denton Sheila A. | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 599 | $69.99 | $41,924 | 25,848 |
| 2025-03-04 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 599 | $58.06 | $34,778 | 26,447 |
| 2025-02-26 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Employee Stock Option (right to buy) | 9,574 | $0.00 | $0 | 19,151 |
| 2025-02-26 | Denton Sheila A. | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 4,495 | $74.08 | $332,990 | 25,848 |
| 2025-02-26 | Denton Sheila A. | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 9,574 | $74.07 | $709,146 | 30,343 |
| 2025-02-26 | Denton Sheila A. | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 9,574 | $58.06 | $555,866 | 39,917 |
| 2025-01-31 | Morrissey Michael James | EVP, Head of Tech. Operations |
Equity grant / award
A
|
Common Stock | 10,552 | $0.00 | $0 | 81,515 |
| 2025-01-21 | Morrissey Michael James | EVP, Head of Tech. Operations |
Other disposed transaction
F
|
Common Stock | 429 | $73.47 | $31,519 | 70,963 |
| 2025-01-17 | SWAIN PAULA J | EVP, Human Resources |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 14,772 | $0.00 | $0 | 14,772 |
| 2025-01-15 | Flannelly Barry P | EVP & General Manager US |
Other disposed transaction
F
|
Common Stock | 3,158 | $72.46 | $228,829 | 53,374 |
| 2025-01-06 | Issa Mohamed Khairie | EVP, Head of US Oncology |
Equity grant / award
A
|
Common Stock | 48,671 | $0.00 | $0 | 48,671 |
| 2024-12-31 | BAKER BROS. ADVISORS LP | — |
Equity grant / award
A
|
Common Stock | 446 | $0.00 | $0 | 28,184,084 |
| 2024-12-16 | Tray Thomas | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 650 | $69.31 | $45,052 | 23,312 |
| 2024-12-13 | Tray Thomas | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 650 | $70.64 | $45,916 | 23,962 |
| 2024-12-09 | SWAIN PAULA J | EVP, Human Resources |
Other disposed transaction
F
|
Common Stock | 873 | $72.11 | $62,952 | 85,203 |
| 2024-11-29 | Iyengar Vijay K | EVP, GMAPPS |
Open-market sell
S
|
Common Stock | 5,683 | $75.37 | $428,328 | 30,658 |
| 2024-11-29 | Iyengar Vijay K | EVP, GMAPPS |
Open-market sell
S
|
Common Stock | 360 | $75.60 | $27,216 | 36,341 |
| 2024-11-06 | Flannelly Barry P | EVP & General Manager US |
Exercise / conversion
M · derivative
|
Employee Stock Option (right to buy) | 2,256 | $0.00 | $0 | 0 |
| 2024-11-06 | Flannelly Barry P | EVP & General Manager US |
Exercise / conversion
M · derivative
|
Employee Stock Option (right to buy) | 1,424 | $0.00 | $0 | 0 |
| 2024-11-06 | Flannelly Barry P | EVP & General Manager US |
Open-market sell
S
|
Common Stock | 2,256 | $78.21 | $176,442 | 58,042 |
| 2024-11-06 | Flannelly Barry P | EVP & General Manager US |
Open-market sell
S
|
Common Stock | 1,424 | $82.00 | $116,768 | 60,298 |
| 2024-11-06 | Flannelly Barry P | EVP & General Manager US |
Exercise / conversion
M
|
Common Stock | 2,256 | $68.62 | $154,807 | 61,722 |
| 2024-11-06 | Flannelly Barry P | EVP & General Manager US |
Exercise / conversion
M
|
Common Stock | 1,424 | $72.27 | $102,912 | 59,466 |
| 2024-10-02 | Denton Sheila A. | EVP & General Counsel |
Other disposed transaction
F
|
Common Stock | 2,136 | $67.63 | $144,458 | 30,343 |
| 2024-10-01 | Heeson Lee | EVP, Head of Incyte Intl |
Equity grant / award
A
|
Common Stock | 26,447 | $0.00 | $0 | 26,447 |
| 2024-09-30 | BAKER BROS. ADVISORS LP | — |
Equity grant / award
A
|
Common Stock | 496 | $0.00 | $0 | 28,183,638 |
| 2024-09-13 | Tray Thomas | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 382 | $63.37 | $24,207 | 24,443 |
| 2024-09-12 | Tray Thomas | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 572 | $62.94 | $36,002 | 24,825 |
| 2024-08-12 | Stein Steven H | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 11,608 | $60.63 | $703,793 | 90,011 |
| 2024-07-25 | Iyengar Vijay K | EVP, GMAPPS |
Open-market sell
S
|
Common Stock | 15,571 | $70.00 | $1,089,970 | 36,701 |
| 2024-07-15 | Stein Steven H | EVP & Chief Medical Officer |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 31,088 | $0.00 | $0 | 31,088 |
| 2024-07-15 | Stein Steven H | EVP & Chief Medical Officer |
Other disposed transaction
F
|
Common Stock | 1,555 | $64.25 | $99,909 | 101,619 |
| 2024-07-15 | Stein Steven H | EVP & Chief Medical Officer |
Equity grant / award
A
|
Common Stock | 13,895 | $0.00 | $0 | 103,174 |
| 2024-07-09 | Flannelly Barry P | EVP & General Manager US |
Open-market sell
S
|
Common Stock | 8,148 | $60.00 | $488,880 | 50,534 |
| 2024-07-02 | Hoppenot Herve | Chairman / CEO |
Other disposed transaction
F
|
Common Stock | 41,723 | $59.02 | $2,462,491 | 460,610 |
| 2024-06-28 | BAKER BROS. ADVISORS LP | — |
Equity grant / award
A
|
Common Stock | 537 | $0.00 | $0 | 28,183,142 |
| 2024-06-12 | BAKER BROS. ADVISORS LP | — |
Equity grant / award
A · derivative
|
Non- Qualified Stock Options (right to buy) | 12,517 | $0.00 | $0 | 12,517 |
| 2024-06-12 | BAKER BROS. ADVISORS LP | — |
Other disposed transaction
D
|
Common Stock | 5,283,206 | $60.00 | $316,992,360 | 28,182,605 |
| 2024-06-12 | BAKER BROS. ADVISORS LP | — |
Other disposed transaction
D
|
Common Stock | 175,977 | $60.00 | $10,558,620 | 2,811,926 |
| 2024-06-12 | BAKER BROS. ADVISORS LP | — |
Equity grant / award
A
|
Common Stock | 2,830 | $0.00 | $0 | 33,465,811 |
| 2024-06-06 | Tray Thomas | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 1,093 | $58.91 | $64,389 | 21,634 |
| 2024-05-07 | BAKER BROS. ADVISORS LP | — |
Exercise / conversion
M · derivative
|
Non- Qualified Stock Options (right to buy) | 15,000 | $0.00 | $0 | 0 |
| 2024-05-07 | BAKER BROS. ADVISORS LP | — |
Exercise / conversion
M
|
Common Stock | 15,000 | $49.01 | $735,150 | 33,462,981 |
| 2024-03-28 | Clancy Paul J | Dir |
Equity grant / award
A
|
Common Stock | 403 | $56.97 | $22,959 | 15,785 |
| 2024-03-25 | Trotta Matteo | EVP, GM, Dermatology US |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 21,868 | $0.00 | $0 | 21,868 |
| 2024-03-25 | Trotta Matteo | EVP, GM, Dermatology US |
Equity grant / award
A
|
Common Stock | 7,828 | $0.00 | $0 | 7,828 |
| 2024-02-14 | Hoppenot Herve | Chairman / CEO |
Equity grant / award
A
|
Common Stock | 41,577 | $0.00 | $0 | 502,333 |
| 2024-02-12 | Stamoulis Christiana | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 387 | $57.84 | $22,384 | 82,606 |
| 2024-01-22 | Morrissey Michael James | EVP, Head of Tech. Operations |
Other disposed transaction
F
|
Common Stock | 108 | $61.50 | $6,642 | 72,300 |
| 2024-01-18 | CAGNONI PABLO J | President, R&D |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 21,843 | $0.00 | $0 | 21,843 |
| 2024-01-17 | Dickinson Jonathan Elliott | EVP, General Manager, Europe |
Other disposed transaction
F
|
Common Stock | 101 | $61.48 | $6,209 | 36,496 |
| 2024-01-17 | Flannelly Barry P | EVP & General Manager US |
Other disposed transaction
F
|
Common Stock | 3,675 | $61.48 | $225,939 | 77,703 |
| 2024-01-16 | Dickinson Jonathan Elliott | EVP, General Manager, Europe |
Other disposed transaction
F
|
Common Stock | 101 | $61.34 | $6,195 | 36,597 |
| 2024-01-03 | Stein Steven H | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 7,365 | $65.51 | $482,481 | 90,218 |
| 2024-01-02 | Iyengar Vijay K | EVP, GMAPPS |
Open-market sell
S
|
Common Stock | 657 | $65.00 | $42,705 | 43,412 |
| 2023-12-29 | BAKER BROS. ADVISORS LP | — |
Equity grant / award
A
|
Common Stock | 556 | $0.00 | $0 | 33,447,438 |
| 2023-12-13 | Tray Thomas | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 1,067 | $62.37 | $66,549 | 23,436 |
| 2023-12-12 | Tray Thomas | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 210 | $57.36 | $12,046 | 24,503 |
| 2023-10-02 | Denton Sheila A. | EVP & General Counsel |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 28,725 | $0.00 | $0 | 28,725 |
| 2023-10-02 | Denton Sheila A. | EVP & General Counsel |
Equity grant / award
A
|
Common Stock | 26,524 | $0.00 | $0 | 26,524 |
| 2023-09-29 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A
|
Common Stock | 510 | $0.00 | $0 | 33,446,882 |
| 2023-09-01 | SWAIN PAULA J | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 8,449 | $65.13 | $550,283 | 77,530 |
| 2023-08-01 | Stein Steven H | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 21,511 | $63.28 | $1,361,216 | 97,583 |
| 2023-07-14 | Tray Thomas | Principal Accounting Officer |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 4,204 | $0.00 | $0 | 4,204 |
| 2023-07-14 | Tray Thomas | Principal Accounting Officer |
Equity grant / award
A
|
Common Stock | 6,015 | $0.00 | $0 | 24,539 |
| 2023-07-03 | Hoppenot Herve | Chairman / CEO |
Other disposed transaction
F
|
Common Stock | 43,467 | $62.08 | $2,698,431 | 391,672 |
| 2023-06-30 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A
|
Common Stock | 512 | $0.00 | $0 | 33,446,372 |
| 2023-06-14 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A · derivative
|
Non- Qualified Stock Option (right to buy) | 11,294 | $0.00 | $0 | 11,294 |
| 2023-06-14 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A
|
Common Stock | 2,505 | $0.00 | $0 | 33,445,860 |
| 2023-06-05 | CAGNONI PABLO J | President, R&D |
Equity grant / award
A
|
Common Stock | 179,613 | $0.00 | $0 | 179,613 |
| 2023-06-05 | CAGNONI PABLO J | President, R&D |
Equity grant / award
A
|
Common Stock | 192,400 | $0.00 | $0 | 192,400 |
| 2023-03-31 | HARRIGAN EDMUND | Dir |
Equity grant / award
A
|
Common Stock | 326 | $72.27 | $23,560 | 8,995 |
| 2023-03-13 | BAKER BROS. ADVISORS LP | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Options (right to buy) | 20,000 | $0.00 | $0 | 0 |
| 2023-03-13 | BAKER BROS. ADVISORS LP | Dir |
Exercise / conversion
M
|
Common Stock | 20,000 | $22.74 | $454,800 | 33,442,926 |
| 2023-02-16 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 3,693 | $0.00 | $0 | 0 |
| 2023-02-16 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M
|
Common Stock | 3,693 | $65.42 | $241,596 | 56,956 |
| 2023-02-13 | Stamoulis Christiana | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 331 | $80.08 | $26,506 | 76,460 |
| 2023-02-13 | Stamoulis Christiana | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 848 | $80.08 | $67,908 | 76,791 |
| 2023-01-31 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 802 | $0.00 | $0 | 0 |
| 2023-01-31 | Pasquale Maria E | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 802 | $84.06 | $67,416 | 68,524 |
| 2023-01-31 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 802 | $74.78 | $59,974 | 69,326 |
| 2023-01-30 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 4,842 | $0.00 | $0 | 0 |
| 2023-01-30 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 5,644 | $0.00 | $0 | 0 |
| 2023-01-30 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 14,374 | $0.00 | $0 | 0 |
| 2023-01-30 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 11,861 | $0.00 | $0 | 0 |
| 2023-01-30 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 10,438 | $0.00 | $0 | 0 |
| 2023-01-30 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 12,865 | $0.00 | $0 | 0 |
| 2023-01-30 | Pasquale Maria E | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 4,842 | $84.73 | $410,263 | 68,524 |
| 2023-01-30 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 4,842 | $74.78 | $362,085 | 73,366 |
| 2023-01-30 | Pasquale Maria E | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 5,644 | $85.07 | $480,135 | 68,524 |
| 2023-01-30 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 5,644 | $83.58 | $471,726 | 74,168 |
| 2023-01-30 | Pasquale Maria E | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 14,374 | $84.73 | $1,217,909 | 68,524 |
| 2023-01-30 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 14,374 | $80.50 | $1,157,107 | 82,898 |
| 2023-01-30 | Pasquale Maria E | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 11,861 | $84.70 | $1,004,627 | 68,524 |
| 2023-01-30 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 11,861 | $72.27 | $857,194 | 80,385 |
| 2023-01-30 | Pasquale Maria E | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 10,438 | $84.70 | $884,099 | 68,524 |
| 2023-01-30 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 10,438 | $68.62 | $716,256 | 78,962 |
| 2023-01-30 | Pasquale Maria E | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 12,865 | $84.69 | $1,089,537 | 68,524 |
| 2023-01-30 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 12,865 | $65.36 | $840,856 | 81,389 |
| 2023-01-26 | Iyengar Vijay K | EVP, GMAPPS |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 7,000 | $0.00 | $0 | 0 |
| 2023-01-26 | Iyengar Vijay K | EVP, GMAPPS |
Open-market sell
S
|
Common Stock | 7,000 | $85.00 | $595,000 | 42,835 |
| 2023-01-26 | Iyengar Vijay K | EVP, GMAPPS |
Exercise / conversion
M
|
Common Stock | 7,000 | $68.62 | $480,340 | 49,835 |
| 2023-01-20 | Iyengar Vijay K | EVP, GMAPPS |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 14,194 | $0.00 | $0 | 14,194 |
| 2023-01-20 | Iyengar Vijay K | EVP, GMAPPS |
Equity grant / award
A
|
Common Stock | 4,980 | $0.00 | $0 | 42,835 |
| 2023-01-19 | Dickinson Jonathan Elliott | EVP, General Manager, Europe |
Other disposed transaction
F
|
Common Stock | 105 | $83.88 | $8,807 | 30,179 |
| 2023-01-17 | Dickinson Jonathan Elliott | EVP, General Manager, Europe |
Other disposed transaction
F
|
Common Stock | 87 | $81.26 | $7,070 | 30,284 |
| 2023-01-15 | Dickinson Jonathan Elliott | EVP, General Manager, Europe |
Other disposed transaction
F
|
Common Stock | 87 | $81.26 | $7,070 | 30,371 |
| 2023-01-04 | Morrissey Michael James | EVP, Head of Tech. Operations |
Other disposed transaction
F
|
Common Stock | 117 | $79.08 | $9,252 | 55,493 |
| 2022-12-30 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A
|
Common Stock | 397 | $0.00 | $0 | 33,422,926 |
| 2022-12-23 | Iyengar Vijay K | EVP, GMAPPS |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 7,000 | $0.00 | $0 | 0 |
| 2022-12-23 | Iyengar Vijay K | EVP, GMAPPS |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 7,866 | $0.00 | $0 | 0 |
| 2022-12-23 | Iyengar Vijay K | EVP, GMAPPS |
Open-market sell
S
|
Common Stock | 1,654 | $80.79 | $133,627 | 37,855 |
| 2022-12-23 | Iyengar Vijay K | EVP, GMAPPS |
Open-market sell
S
|
Common Stock | 804 | $80.77 | $64,939 | 39,509 |
| 2022-12-23 | Iyengar Vijay K | EVP, GMAPPS |
Open-market sell
S
|
Common Stock | 7,000 | $80.80 | $565,600 | 40,313 |
| 2022-12-23 | Iyengar Vijay K | EVP, GMAPPS |
Exercise / conversion
M
|
Common Stock | 7,000 | $68.62 | $480,340 | 47,313 |
| 2022-12-23 | Iyengar Vijay K | EVP, GMAPPS |
Open-market sell
S
|
Common Stock | 7,866 | $80.80 | $635,573 | 40,313 |
| 2022-12-23 | Iyengar Vijay K | EVP, GMAPPS |
Exercise / conversion
M
|
Common Stock | 7,866 | $72.86 | $573,117 | 48,179 |
| 2022-12-19 | Tray Thomas | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 1,223 | $82.16 | $100,482 | 16,606 |
| 2022-12-12 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Other disposed transaction
F
|
Common Stock | 533 | $82.36 | $43,898 | 50,702 |
| 2022-10-19 | HARRIGAN EDMUND | Dir |
Equity grant / award
A
|
Common Stock | 165 | $69.59 | $11,482 | 8,367 |
| 2022-10-03 | Schaffert Susanne | Dir |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 6,751 | $0.00 | $0 | 6,751 |
| 2022-10-03 | Schaffert Susanne | Dir |
Equity grant / award
A
|
Common Stock | 1,625 | $0.00 | $0 | 1,625 |
| 2022-09-30 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A
|
Common Stock | 457 | $0.00 | $0 | 33,422,529 |
| 2022-07-22 | Tray Thomas | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 1,564 | $83.13 | $130,015 | 17,702 |
| 2022-07-07 | Iyengar Vijay K | EVP, GMAPPS |
Open-market sell
S
|
Common Stock | 5,787 | $79.38 | $459,372 | 40,313 |
| 2022-07-05 | Tray Thomas | Principal Accounting Officer |
Other disposed transaction
F
|
Common Stock | 987 | $79.25 | $78,220 | 19,266 |
| 2022-07-02 | Tray Thomas | Principal Accounting Officer |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 2,810 | $0.00 | $0 | 2,810 |
| 2022-07-02 | Tray Thomas | Principal Accounting Officer |
Equity grant / award
A
|
Common Stock | 4,149 | $0.00 | $0 | 20,253 |
| 2022-06-30 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A
|
Common Stock | 433 | $0.00 | $0 | 33,422,072 |
| 2022-06-28 | Stein Steven H | EVP & Chief Medical Officer |
Other disposed transaction
F
|
Common Stock | 11,488 | $75.63 | $868,837 | 122,335 |
| 2022-06-15 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A · derivative
|
Non-Qualified Stock Options (right to buy) | 9,124 | $0.00 | $0 | 9,124 |
| 2022-06-15 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A
|
Common Stock | 2,144 | $0.00 | $0 | 33,421,639 |
| 2022-04-09 | Pasquale Maria E | EVP & General Counsel |
Other disposed transaction
F
|
Common Stock | 517 | $80.95 | $41,851 | 53,058 |
| 2022-04-08 | Flannelly Barry P | EVP & General Manager US |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 21,348 | $0.00 | $0 | 0 |
| 2022-04-08 | Flannelly Barry P | EVP & General Manager US |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 20,516 | $0.00 | $0 | 0 |
| 2022-04-08 | Flannelly Barry P | EVP & General Manager US |
Open-market sell
S
|
Common Stock | 1,248 | $82.96 | $103,534 | 65,163 |
| 2022-04-08 | Flannelly Barry P | EVP & General Manager US |
Open-market sell
S
|
Common Stock | 881 | $82.96 | $73,088 | 66,411 |
| 2022-04-08 | Flannelly Barry P | EVP & General Manager US |
Open-market sell
S
|
Common Stock | 21,348 | $84.00 | $1,793,232 | 67,292 |
| 2022-04-08 | Flannelly Barry P | EVP & General Manager US |
Exercise / conversion
M
|
Common Stock | 21,348 | $72.27 | $1,542,820 | 88,640 |
| 2022-04-08 | Flannelly Barry P | EVP & General Manager US |
Open-market sell
S
|
Common Stock | 20,516 | $83.01 | $1,703,033 | 67,292 |
| 2022-04-08 | Flannelly Barry P | EVP & General Manager US |
Exercise / conversion
M
|
Common Stock | 20,516 | $68.62 | $1,407,808 | 87,808 |
| 2022-03-31 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A
|
Common Stock | 440 | $0.00 | $0 | 33,419,495 |
| 2022-03-10 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 175,795 | $73.31 | $12,887,303 | 33,419,055 |
| 2022-03-10 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 14,490 | $73.31 | $1,062,243 | 2,941,147 |
| 2022-03-10 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 1,017 | $71.95 | $73,177 | 33,243,260 |
| 2022-03-10 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 84 | $71.95 | $6,044 | 2,926,657 |
| 2022-03-10 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 25,107 | $71.90 | $1,805,126 | 33,242,243 |
| 2022-03-10 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 2,070 | $71.90 | $148,827 | 2,926,573 |
| 2022-03-09 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 65,147 | $71.72 | $4,672,408 | 33,217,136 |
| 2022-03-09 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 5,370 | $71.72 | $385,142 | 2,924,503 |
| 2022-03-08 | BAKER BROS. ADVISORS LP | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Options (right to buy) | 20,000 | $0.00 | $0 | 0 |
| 2022-03-08 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 92,385 | $70.67 | $6,529,310 | 33,151,989 |
| 2022-03-08 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 7,615 | $70.67 | $538,190 | 2,919,133 |
| 2022-03-08 | BAKER BROS. ADVISORS LP | Dir |
Exercise / conversion
M
|
Common Stock | 20,000 | $22.05 | $441,000 | 33,059,604 |
| 2022-02-22 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 92,234 | $68.07 | $6,278,507 | 33,039,604 |
| 2022-02-22 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 7,566 | $68.07 | $515,029 | 2,891,518 |
| 2022-02-18 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 22,178 | $68.43 | $1,517,656 | 32,947,370 |
| 2022-02-18 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 1,827 | $68.43 | $125,023 | 2,883,952 |
| 2022-02-18 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 100,731 | $68.37 | $6,886,696 | 32,925,192 |
| 2022-02-18 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 8,296 | $68.37 | $567,174 | 2,882,125 |
| 2022-02-17 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 285,672 | $67.74 | $19,352,821 | 32,824,461 |
| 2022-02-17 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 7,300 | $67.39 | $491,984 | 32,538,789 |
| 2022-02-14 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 182,326 | $66.04 | $12,040,390 | 32,531,489 |
| 2022-02-14 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 320,526 | $66.02 | $21,159,973 | 32,349,163 |
| 2022-02-11 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 10,985 | $66.95 | $735,433 | 32,028,637 |
| 2022-02-11 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 265,522 | $66.81 | $17,740,295 | 32,017,652 |
| 2022-02-11 | Stamoulis Christiana | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 331 | $66.76 | $22,098 | 56,285 |
| 2022-02-11 | Stamoulis Christiana | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 846 | $66.76 | $56,479 | 56,616 |
| 2022-02-10 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 772,751 | $67.54 | $52,192,839 | 31,752,130 |
| 2022-02-10 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 6,100 | $67.20 | $409,899 | 30,979,379 |
| 2022-02-10 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 40,164 | $66.57 | $2,673,577 | 30,973,279 |
| 2022-01-31 | Dickinson Jonathan Elliott | EVP, General Manager, Europe |
Open-market sell
S
|
Common Stock | 7,375 | $74.19 | $547,151 | 30,214 |
| 2022-01-24 | Morrissey Michael James | EVP, Head of Tech. Operations |
Other disposed transaction
F
|
Common Stock | 78 | $75.34 | $5,877 | 55,610 |
| 2022-01-19 | Morrissey Michael James | EVP, Head of Tech. Operations |
Equity grant / award
A
|
Common Stock | 6,959 | $0.00 | $0 | 55,688 |
| 2022-01-19 | Trower Paul | Principal Accounting Officer |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 3,250 | $0.00 | $0 | 3,250 |
| 2022-01-18 | Morrissey Michael James | EVP, Head of Tech. Operations |
Other disposed transaction
F
|
Common Stock | 101 | $75.01 | $7,576 | 48,729 |
| 2022-01-07 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Non Qualfied Stock Option (right to buy) | 10,870 | $0.00 | $0 | 0 |
| 2022-01-07 | SWAIN PAULA J | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 10,870 | $73.31 | $796,880 | 72,371 |
| 2022-01-07 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 10,870 | $73.21 | $795,793 | 83,241 |
| 2022-01-04 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Non Qualfied Stock Option (right to buy) | 9,319 | $0.00 | $0 | 10,870 |
| 2022-01-04 | SWAIN PAULA J | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 9,319 | $73.46 | $684,574 | 72,371 |
| 2022-01-04 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 9,319 | $73.21 | $682,244 | 81,690 |
| 2022-01-04 | Morrissey Michael James | EVP, Head of Tech. Operations |
Other disposed transaction
F
|
Common Stock | 136 | $71.81 | $9,766 | 48,931 |
| 2022-01-03 | Trower Paul | Principal Accounting Officer |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 1,396 | $0.00 | $0 | 0 |
| 2022-01-03 | Trower Paul | Principal Accounting Officer |
Exercise / conversion
M · derivative
|
Non- Qualified Stock Option (right to buy) | 6,818 | $0.00 | $0 | 0 |
| 2022-01-03 | Trower Paul | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 1,396 | $73.31 | $102,341 | 32,268 |
| 2022-01-03 | Trower Paul | Principal Accounting Officer |
Exercise / conversion
M
|
Common Stock | 1,396 | $73.21 | $102,201 | 33,664 |
| 2022-01-03 | Trower Paul | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 6,818 | $73.31 | $499,828 | 32,268 |
| 2022-01-03 | Trower Paul | Principal Accounting Officer |
Exercise / conversion
M
|
Common Stock | 6,818 | $73.21 | $499,146 | 39,086 |
| 2022-01-01 | SWAIN PAULA J | EVP, Human Resources |
Equity grant / award
A
|
Common Stock | 8,678 | $0.00 | $0 | 72,371 |
| 2021-12-31 | HARRIGAN EDMUND | Dir |
Equity grant / award
A
|
Common Stock | 253 | $73.40 | $18,570 | 5,332 |
| 2021-12-23 | DIXON WENDY L | Dir |
Exercise / conversion
M · derivative
|
Non Qualfied Stock Option (right to buy) | 20,000 | $0.00 | $0 | 0 |
| 2021-12-23 | DIXON WENDY L | Dir |
Open-market sell
S
|
Common Stock | 20,000 | $22.05 | $441,000 | 17,259 |
| 2021-12-23 | DIXON WENDY L | Dir |
Exercise / conversion
M
|
Common Stock | 20,000 | $73.25 | $1,465,000 | 37,259 |
| 2021-12-17 | BAKER BROS. ADVISORS LP | — |
Open-market buy
P
|
Common Stock | 193,997 | $72.91 | $14,144,224 | 30,932,696 |
| 2021-12-17 | BAKER BROS. ADVISORS LP | — |
Open-market buy
P
|
Common Stock | 881,875 | $72.77 | $64,177,924 | 30,738,699 |
| 2021-12-16 | BAKER BROS. ADVISORS LP | — |
Open-market buy
P
|
Common Stock | 29,703 | $72.00 | $2,138,616 | 29,856,824 |
| 2021-12-16 | BAKER BROS. ADVISORS LP | — |
Open-market buy
P
|
Common Stock | 139,612 | $71.96 | $10,045,795 | 29,827,121 |
| 2021-12-15 | BAKER BROS. ADVISORS LP | — |
Open-market buy
P
|
Common Stock | 288,368 | $71.91 | $20,736,197 | 29,687,509 |
| 2021-12-15 | BAKER BROS. ADVISORS LP | — |
Open-market buy
P
|
Common Stock | 5,382 | $71.03 | $382,302 | 29,399,141 |
| 2021-12-15 | BAKER BROS. ADVISORS LP | — |
Open-market buy
P
|
Common Stock | 9,893 | $70.24 | $694,840 | 29,393,759 |
| 2021-12-15 | BAKER BROS. ADVISORS LP | — |
Open-market buy
P
|
Common Stock | 36,476 | $69.63 | $2,539,700 | 29,383,866 |
| 2021-12-15 | BAKER BROS. ADVISORS LP | — |
Open-market buy
P
|
Common Stock | 9,352 | $68.52 | $640,841 | 29,347,390 |
| 2021-12-15 | BAKER BROS. ADVISORS LP | — |
Open-market buy
P
|
Common Stock | 861 | $67.90 | $58,460 | 29,338,038 |
| 2021-12-10 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Other disposed transaction
F
|
Common Stock | 533 | $65.40 | $34,858 | 33,464 |
| 2021-11-19 | SWAIN PAULA J | EVP, Human Resources |
Equity grant / award
A
|
Common Stock | 2,355 | $0.00 | $0 | 63,693 |
| 2021-11-19 | SWAIN PAULA J | EVP, Human Resources |
Equity grant / award
A
|
Common Stock | 379 | $0.00 | $0 | 61,338 |
| 2021-10-01 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 389 | $68.67 | $26,713 | 31,263 |
| 2021-09-30 | HARRIGAN EDMUND | Dir |
Equity grant / award
A
|
Common Stock | 237 | $68.78 | $16,301 | 5,079 |
| 2021-09-27 | BRAWLEY OTIS W | Dir |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option (right to buy) | 5,910 | $0.00 | $0 | 5,910 |
| 2021-09-27 | BRAWLEY OTIS W | Dir |
Equity grant / award
A
|
Common Stock | 1,255 | $0.00 | $0 | 1,255 |
| 2021-09-24 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 382 | $0.00 | $0 | 1,912 |
| 2021-09-24 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 382 | $65.36 | $24,968 | 36,187 |
| 2021-09-20 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 1,356 | $0.00 | $0 | 0 |
| 2021-09-20 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 1,356 | $73.21 | $99,273 | 60,959 |
| 2021-09-01 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 388 | $76.71 | $29,763 | 31,652 |
| 2021-08-02 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 389 | $77.49 | $30,144 | 32,040 |
| 2021-07-29 | Iyengar Vijay K | EVP GPS, BD, & Licensing |
Open-market sell
S
|
Common Stock | 4,911 | $78.29 | $384,482 | 27,005 |
| 2021-07-06 | Trower Paul | Principal Accounting Officer |
Other disposed transaction
F
|
Common Stock | 104 | $83.34 | $8,667 | 32,268 |
| 2021-07-02 | Trower Paul | Principal Accounting Officer |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 3,250 | $0.00 | $0 | 3,250 |
| 2021-07-02 | Trower Paul | Principal Accounting Officer |
Other disposed transaction
F
|
Common Stock | 872 | $83.58 | $72,882 | 32,372 |
| 2021-07-02 | Trower Paul | Principal Accounting Officer |
Equity grant / award
A
|
Common Stock | 4,521 | $0.00 | $0 | 33,244 |
| 2021-07-01 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 396 | $84.09 | $33,300 | 26,149 |
| 2021-06-30 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A
|
Common Stock | 345 | $0.00 | $0 | 29,336,784 |
| 2021-06-28 | Stein Steven H | EVP & Chief Medical Officer |
Other disposed transaction
F
|
Common Stock | 22,079 | $85.61 | $1,890,183 | 97,665 |
| 2021-06-18 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 255 | $0.00 | $0 | 2,294 |
| 2021-06-18 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 255 | $65.36 | $16,667 | 30,193 |
| 2021-06-10 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 3,845 | $0.00 | $0 | 26,914 |
| 2021-06-10 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 3,845 | $87.00 | $334,515 | 26,545 |
| 2021-06-10 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M
|
Common Stock | 3,845 | $65.42 | $251,540 | 30,390 |
| 2021-06-01 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 395 | $84.13 | $33,231 | 26,545 |
| 2021-05-26 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A · derivative
|
Non-Qualified Stock Options (right to buy) | 8,010 | $0.00 | $0 | 8,010 |
| 2021-05-26 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A
|
Common Stock | 1,923 | $0.00 | $0 | 29,336,439 |
| 2021-05-14 | BAKER BROS. ADVISORS LP | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Options (right to buy) | 20,000 | $0.00 | $0 | 0 |
| 2021-05-14 | BAKER BROS. ADVISORS LP | Dir |
Exercise / conversion
M
|
Common Stock | 20,000 | $18.97 | $379,400 | 29,334,516 |
| 2021-05-03 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 396 | $85.40 | $33,818 | 26,940 |
| 2021-04-23 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 127 | $0.00 | $0 | 2,549 |
| 2021-04-23 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 127 | $65.36 | $8,301 | 29,938 |
| 2021-04-09 | Pasquale Maria E | EVP & General Counsel |
Other disposed transaction
F
|
Common Stock | 517 | $79.96 | $41,339 | 29,811 |
| 2021-04-01 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 396 | $81.57 | $32,302 | 27,336 |
| 2021-03-31 | FOUSE JACQUALYN A | Dir |
Equity grant / award
A
|
Common Stock | 251 | $81.27 | $20,399 | 5,510 |
| 2021-03-29 | Morrissey Michael James | EVP, Head of Tech. Operations |
Open-market sell
S
|
Common Stock | 20,000 | $81.08 | $1,621,600 | 45,452 |
| 2021-03-12 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 128 | $0.00 | $0 | 2,676 |
| 2021-03-12 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 128 | $65.36 | $8,366 | 30,328 |
| 2021-03-01 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 395 | $79.73 | $31,493 | 27,732 |
| 2021-02-23 | Hoppenot Herve | Chairman / CEO |
Open-market buy
P
|
Common Stock | 12,925 | $77.37 | $1,000,007 | 284,231 |
| 2021-02-16 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 127 | $0.00 | $0 | 2,804 |
| 2021-02-16 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 127 | $65.36 | $8,301 | 30,200 |
| 2021-02-11 | Stamoulis Christiana | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 1,210 | $84.99 | $102,838 | 32,611 |
| 2021-02-01 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 961 | $0.00 | $0 | 30,759 |
| 2021-02-01 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 395 | $90.00 | $35,550 | 28,127 |
| 2021-02-01 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 961 | $90.00 | $86,490 | 28,522 |
| 2021-02-01 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M
|
Common Stock | 961 | $65.42 | $62,869 | 29,483 |
| 2021-01-25 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 19,986 | $0.00 | $0 | 0 |
| 2021-01-25 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 1,559 | $0.00 | $0 | 0 |
| 2021-01-25 | Wenqing Yao | EVP, Head of Discovery Chem |
Open-market sell
S
|
Common Stock | 19,986 | $100.00 | $1,998,600 | 143,784 |
| 2021-01-25 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M
|
Common Stock | 19,986 | $73.21 | $1,463,175 | 163,770 |
| 2021-01-25 | Wenqing Yao | EVP, Head of Discovery Chem |
Open-market sell
S
|
Common Stock | 1,559 | $100.00 | $155,900 | 143,784 |
| 2021-01-25 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M
|
Common Stock | 1,559 | $73.21 | $114,134 | 145,343 |
| 2021-01-15 | Stamoulis Christiana | EVP & Chief Financial Officer |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 12,743 | $0.00 | $0 | 12,743 |
| 2021-01-15 | Stamoulis Christiana | EVP & Chief Financial Officer |
Equity grant / award
A
|
Common Stock | 11,522 | $0.00 | $0 | 33,821 |
| 2021-01-11 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 127 | $0.00 | $0 | 2,931 |
| 2021-01-11 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 127 | $65.36 | $8,301 | 30,073 |
| 2021-01-04 | Morrissey Michael James | EVP, Head of Tech. Operations |
Other disposed transaction
F
|
Common Stock | 136 | $86.45 | $11,757 | 48,421 |
| 2020-12-31 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A
|
Common Stock | 343 | $0.00 | $0 | 29,314,152 |
| 2020-12-11 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 128 | $0.00 | $0 | 3,058 |
| 2020-12-11 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 128 | $65.36 | $8,366 | 29,946 |
| 2020-12-10 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Other disposed transaction
F
|
Common Stock | 720 | $82.05 | $59,076 | 28,522 |
| 2020-11-16 | Wenqing Yao | EVP, Head of Discovery Chem |
Equity grant / award
A
|
Common Stock | 1,232 | $0.00 | $0 | 156,851 |
| 2020-11-12 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 127 | $0.00 | $0 | 3,186 |
| 2020-11-12 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 127 | $65.36 | $8,301 | 28,586 |
| 2020-11-10 | BIENAIME JEAN JACQUES | Dir |
Open-market sell
S
|
Common Stock | 798 | $83.00 | $66,234 | 8,646 |
| 2020-11-06 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 961 | $0.00 | $0 | 31,720 |
| 2020-11-06 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 961 | $85.17 | $81,848 | 28,010 |
| 2020-11-06 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M
|
Common Stock | 961 | $65.42 | $62,869 | 28,971 |
| 2020-11-02 | Flannelly Barry P | EVP & General Manager US |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 20,000 | $0.00 | $0 | 0 |
| 2020-11-02 | Flannelly Barry P | EVP & General Manager US |
Open-market sell
S
|
Common Stock | 20,000 | $86.60 | $1,732,000 | 39,984 |
| 2020-11-02 | Flannelly Barry P | EVP & General Manager US |
Exercise / conversion
M
|
Common Stock | 20,000 | $48.44 | $968,800 | 59,984 |
| 2020-10-12 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 128 | $0.00 | $0 | 3,313 |
| 2020-10-12 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 128 | $65.36 | $8,366 | 28,459 |
| 2020-10-09 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Non Qualified Stock Option (right to buy) | 1,423 | $0.00 | $0 | 10,438 |
| 2020-10-09 | Pasquale Maria E | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 1,423 | $95.00 | $135,185 | 28,331 |
| 2020-10-09 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 1,423 | $68.62 | $97,646 | 29,754 |
| 2020-10-06 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 961 | $0.00 | $0 | 32,681 |
| 2020-10-06 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 961 | $91.97 | $88,383 | 28,010 |
| 2020-10-06 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M
|
Common Stock | 961 | $65.42 | $62,869 | 28,971 |
| 2020-09-30 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A
|
Common Stock | 317 | $0.00 | $0 | 29,313,809 |
| 2020-09-11 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 127 | $0.00 | $0 | 3,441 |
| 2020-09-11 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 127 | $65.36 | $8,301 | 28,331 |
| 2020-09-10 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Non Qualified Stock Option (right to buy) | 2,193 | $0.00 | $0 | 12,865 |
| 2020-09-10 | Pasquale Maria E | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 2,193 | $90.83 | $199,190 | 28,204 |
| 2020-09-10 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 2,193 | $65.36 | $143,334 | 30,397 |
| 2020-09-08 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 961 | $0.00 | $0 | 33,642 |
| 2020-09-08 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 961 | $88.94 | $85,471 | 28,010 |
| 2020-09-08 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M
|
Common Stock | 961 | $65.42 | $62,869 | 28,971 |
| 2020-08-27 | DIXON WENDY L | Dir |
Exercise / conversion
M · derivative
|
Non Qualfied Stock Option (right to buy) | 20,000 | $0.00 | $0 | 0 |
| 2020-08-27 | DIXON WENDY L | Dir |
Open-market sell
S
|
Common Stock | 20,000 | $94.51 | $1,890,200 | 14,243 |
| 2020-08-27 | DIXON WENDY L | Dir |
Exercise / conversion
M
|
Common Stock | 20,000 | $18.97 | $379,400 | 34,243 |
| 2020-08-10 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 128 | $0.00 | $0 | 3,568 |
| 2020-08-10 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 128 | $65.36 | $8,366 | 28,204 |
| 2020-08-06 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 961 | $0.00 | $0 | 34,603 |
| 2020-08-06 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 961 | $97.80 | $93,986 | 28,010 |
| 2020-08-06 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M
|
Common Stock | 961 | $65.42 | $62,869 | 28,971 |
| 2020-07-15 | Wenqing Yao | EVP, Head of Discovery Chem |
Other disposed transaction
F
|
Common Stock | 639 | $104.25 | $66,616 | 155,619 |
| 2020-07-13 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 2,419 | $0.00 | $0 | 0 |
| 2020-07-13 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M
|
Common Stock | 2,419 | $65.42 | $158,251 | 28,010 |
| 2020-07-10 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 127 | $0.00 | $0 | 3,696 |
| 2020-07-10 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 127 | $65.36 | $8,301 | 28,076 |
| 2020-07-08 | Iyengar Vijay K | EVP GPS, BD, & Licensing |
Open-market sell
S
|
Common Stock | 475 | $108.56 | $51,566 | 25,926 |
| 2020-07-07 | Iyengar Vijay K | EVP GPS, BD, & Licensing |
Open-market sell
S
|
Common Stock | 3,120 | $107.98 | $336,898 | 26,401 |
| 2020-07-06 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 15,648 | $0.00 | $0 | 0 |
| 2020-07-06 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 905 | $0.00 | $0 | 0 |
| 2020-07-06 | Wenqing Yao | EVP, Head of Discovery Chem |
Open-market sell
S
|
Common Stock | 15,648 | $107.32 | $1,679,343 | 156,258 |
| 2020-07-06 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M
|
Common Stock | 15,648 | $64.55 | $1,010,078 | 171,906 |
| 2020-07-06 | Wenqing Yao | EVP, Head of Discovery Chem |
Open-market sell
S
|
Common Stock | 905 | $107.32 | $97,125 | 156,258 |
| 2020-07-06 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M
|
Common Stock | 905 | $64.55 | $58,418 | 157,163 |
| 2020-07-06 | Wenqing Yao | EVP, Head of Discovery Chem |
Other disposed transaction
F
|
Common Stock | 404 | $107.79 | $43,547 | 156,258 |
| 2020-07-02 | Wenqing Yao | EVP, Head of Discovery Chem |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 12,743 | $0.00 | $0 | 12,743 |
| 2020-07-02 | Wenqing Yao | EVP, Head of Discovery Chem |
Other disposed transaction
F
|
Common Stock | 2,187 | $106.47 | $232,850 | 156,662 |
| 2020-07-02 | Wenqing Yao | EVP, Head of Discovery Chem |
Equity grant / award
A
|
Common Stock | 6,661 | $0.00 | $0 | 158,849 |
| 2020-06-30 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A
|
Common Stock | 294 | $0.00 | $0 | 29,313,492 |
| 2020-06-26 | Hoppenot Herve | Chairman / CEO |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 119,501 | $0.00 | $0 | 0 |
| 2020-06-26 | Hoppenot Herve | Chairman / CEO |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 4,647 | $0.00 | $0 | 0 |
| 2020-06-26 | Hoppenot Herve | Chairman / CEO |
Open-market sell
S
|
Common Stock | 119,501 | $102.91 | $12,297,848 | 240,603 |
| 2020-06-26 | Hoppenot Herve | Chairman / CEO |
Exercise / conversion
M
|
Common Stock | 119,501 | $64.55 | $7,713,790 | 360,104 |
| 2020-06-26 | Hoppenot Herve | Chairman / CEO |
Open-market sell
S
|
Common Stock | 4,647 | $102.91 | $478,223 | 240,603 |
| 2020-06-26 | Hoppenot Herve | Chairman / CEO |
Exercise / conversion
M
|
Common Stock | 4,647 | $64.55 | $299,964 | 245,250 |
| 2020-06-23 | Trower Paul | Principal Accounting Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 6,943 | $0.00 | $0 | 0 |
| 2020-06-23 | Trower Paul | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 6,943 | $110.00 | $763,730 | 21,734 |
| 2020-06-23 | Trower Paul | Principal Accounting Officer |
Exercise / conversion
M
|
Common Stock | 6,943 | $64.55 | $448,171 | 28,677 |
| 2020-06-22 | Dickinson Jonathan Elliott | EVP, General Manager, Europe |
Open-market sell
S
|
Common Stock | 9,000 | $105.31 | $947,790 | 21,762 |
| 2020-06-19 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Non Qualified Stock Option (right to buy) | 1,423 | $0.00 | $0 | 11,861 |
| 2020-06-19 | Pasquale Maria E | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 1,423 | $100.00 | $142,300 | 23,661 |
| 2020-06-19 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 1,423 | $72.27 | $102,840 | 25,084 |
| 2020-06-18 | Wenqing Yao | EVP, Head of Discovery Chem |
Equity grant / award
A
|
Common Stock | 25,000 | $0.00 | $0 | 152,188 |
| 2020-06-17 | INCYTE CORP | 10% |
Open-market sell
S
|
Common Stock | 141,920 | $3.66 | $518,831 | 16,972,968 |
| 2020-06-16 | INCYTE CORP | 10% |
Open-market sell
S
|
Common Stock | 72,080 | $3.66 | $264,007 | 17,114,888 |
| 2020-06-15 | INCYTE CORP | 10% |
Open-market sell
S
|
Common Stock | 384,025 | $3.57 | $1,372,160 | 17,186,968 |
| 2020-06-12 | INCYTE CORP | 10% |
Open-market sell
S
|
Common Stock | 9,100 | $3.58 | $32,556 | 17,570,993 |
| 2020-06-12 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 127 | $0.00 | $0 | 3,823 |
| 2020-06-12 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 127 | $65.36 | $8,301 | 23,661 |
| 2020-06-11 | INCYTE CORP | 10% |
Open-market sell
S
|
Common Stock | 183,875 | $3.77 | $692,786 | 17,580,093 |
| 2020-06-10 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Non Qualified Stock Option (right to buy) | 2,192 | $0.00 | $0 | 15,058 |
| 2020-06-10 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Non Qualified Stock Option (right to buy) | 1,423 | $0.00 | $0 | 11,861 |
| 2020-06-10 | Pasquale Maria E | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 2,192 | $94.19 | $206,464 | 23,534 |
| 2020-06-10 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 2,192 | $65.36 | $143,269 | 25,726 |
| 2020-06-10 | Pasquale Maria E | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 1,423 | $95.00 | $135,185 | 23,534 |
| 2020-06-10 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 1,423 | $68.62 | $97,646 | 24,957 |
| 2020-06-08 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 961 | $0.00 | $0 | 36,525 |
| 2020-06-08 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 961 | $91.87 | $88,287 | 19,987 |
| 2020-06-08 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M
|
Common Stock | 961 | $65.42 | $62,869 | 20,948 |
| 2020-05-28 | BAKER BROS. ADVISORS LP | Dir |
Open-market buy
P
|
Common Stock | 1 | $102.55 | $103 | 29,313,198 |
| 2020-05-26 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A · derivative
|
Non-Qualified Stock Options (right to buy) | 10,514 | $0.00 | $0 | 10,514 |
| 2020-05-26 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A
|
Common Stock | 1,282 | $0.00 | $0 | 29,313,197 |
| 2020-05-11 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 128 | $0.00 | $0 | 3,950 |
| 2020-05-11 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 128 | $65.36 | $8,366 | 23,534 |
| 2020-05-06 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 961 | $0.00 | $0 | 37,486 |
| 2020-05-06 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Open-market sell
S
|
Common Stock | 961 | $96.84 | $93,063 | 19,987 |
| 2020-05-06 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Exercise / conversion
M
|
Common Stock | 961 | $65.42 | $62,869 | 20,948 |
| 2020-04-28 | BAKER BROS. ADVISORS LP | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Options (right to buy) | 20,000 | — | $266,800 | 0 |
| 2020-04-28 | BAKER BROS. ADVISORS LP | Dir |
Exercise / conversion
M
|
Common Stock | 20,000 | $13.34 | $266,800 | 29,311,915 |
| 2020-04-17 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Non Qualified Stock Option (right to buy) | 9,488 | $0.00 | $0 | 13,284 |
| 2020-04-17 | Pasquale Maria E | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 9,488 | $100.00 | $948,800 | 22,899 |
| 2020-04-17 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 9,488 | $72.27 | $685,698 | 32,837 |
| 2020-04-17 | Trower Paul | Principal Accounting Officer |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 1,143 | $0.00 | $0 | 0 |
| 2020-04-17 | Trower Paul | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 1,143 | $100.00 | $114,300 | 21,324 |
| 2020-04-17 | Trower Paul | Principal Accounting Officer |
Exercise / conversion
M
|
Common Stock | 1,143 | $64.55 | $73,781 | 22,467 |
| 2020-04-16 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Non Qualified Stock Option (right to buy) | 9,488 | $0.00 | $0 | 13,284 |
| 2020-04-16 | Pasquale Maria E | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 9,488 | $95.00 | $901,360 | 22,899 |
| 2020-04-16 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 9,488 | $68.62 | $651,067 | 32,837 |
| 2020-04-14 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Non Qualified Stock Option (right to buy) | 17,827 | $0.00 | $0 | 17,250 |
| 2020-04-14 | Pasquale Maria E | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 17,827 | $90.00 | $1,604,430 | 22,899 |
| 2020-04-14 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 17,827 | $65.36 | $1,165,173 | 40,726 |
| 2020-04-13 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 127 | $0.00 | $0 | 4,078 |
| 2020-04-13 | Pasquale Maria E | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 965 | $85.68 | $82,681 | 22,899 |
| 2020-04-13 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 127 | $65.36 | $8,301 | 23,864 |
| 2020-04-09 | Pasquale Maria E | EVP & General Counsel |
Other disposed transaction
F
|
Common Stock | 517 | $86.81 | $44,881 | 23,737 |
| 2020-04-06 | Pasquale Maria E | EVP & General Counsel |
Open-market sell
S
|
Common Stock | 1,842 | $85.00 | $156,570 | 24,254 |
| 2020-03-31 | HARRIGAN EDMUND | Dir |
Equity grant / award
A
|
Common Stock | 202 | $73.23 | $14,792 | 664 |
| 2020-03-26 | High Katherine A | Dir |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option | 1,285 | $0.00 | $0 | 1,285 |
| 2020-03-26 | High Katherine A | Dir |
Equity grant / award
A
|
Common Stock | 139 | $0.00 | $0 | 139 |
| 2020-03-11 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 128 | $0.00 | $0 | 4,205 |
| 2020-03-11 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 128 | $65.36 | $8,366 | 26,096 |
| 2020-02-21 | BROOKE PAUL A | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 20,000 | $0.00 | $0 | 0 |
| 2020-02-21 | BROOKE PAUL A | Dir |
Exercise / conversion
M
|
Common Stock | 20,000 | $13.34 | $266,800 | 221,584 |
| 2020-02-19 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,500 | $0.00 | $0 | 1,639 |
| 2020-02-19 | SWAIN PAULA J | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 2,500 | $80.00 | $200,000 | 48,493 |
| 2020-02-19 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 2,500 | $64.55 | $161,375 | 50,993 |
| 2020-02-13 | Iyengar Vijay K | EVP GPS, BD, & Licensing |
Equity grant / award
A
|
Common Stock | 6,881 | $0.00 | $0 | 24,490 |
| 2020-02-11 | Stamoulis Christiana | EVP & Chief Financial Officer |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 34,240 | $0.00 | $0 | 34,240 |
| 2020-02-11 | Stamoulis Christiana | EVP & Chief Financial Officer |
Other disposed transaction
F
|
Common Stock | 780 | $76.14 | $59,389 | 14,089 |
| 2020-02-11 | Stamoulis Christiana | EVP & Chief Financial Officer |
Equity grant / award
A
|
Common Stock | 4,268 | $76.14 | $324,966 | 14,869 |
| 2020-02-10 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 127 | $0.00 | $0 | 4,333 |
| 2020-02-10 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 127 | $65.36 | $8,301 | 19,087 |
| 2020-02-05 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 17,542 | $0.00 | $0 | 0 |
| 2020-02-05 | Wenqing Yao | EVP, Head of Discovery Chem |
Open-market sell
S
|
Common Stock | 17,542 | $75.97 | $1,332,666 | 95,308 |
| 2020-02-05 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M
|
Common Stock | 17,542 | $18.32 | $321,369 | 112,850 |
| 2020-01-23 | Morrissey Michael James | EVP, Head of Tech. Operations |
Other disposed transaction
F
|
Common Stock | 64 | $78.24 | $5,007 | 48,557 |
| 2020-01-17 | Trower Paul | Principal Accounting Officer |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 2,290 | $0.00 | $0 | 2,290 |
| 2020-01-17 | Trower Paul | Principal Accounting Officer |
Equity grant / award
A
|
Common Stock | 4,018 | $0.00 | $0 | 21,324 |
| 2020-01-15 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,500 | $0.00 | $0 | 4,139 |
| 2020-01-15 | SWAIN PAULA J | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 2,500 | $81.12 | $202,800 | 41,612 |
| 2020-01-15 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 2,500 | $64.55 | $161,375 | 44,112 |
| 2020-01-10 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 127 | $0.00 | $0 | 4,460 |
| 2020-01-10 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 127 | $65.36 | $8,301 | 18,960 |
| 2020-01-06 | Dickinson Jonathan Elliott | EVP, General Manager, Europe |
Other disposed transaction
F
|
Common Stock | 111 | $77.34 | $8,585 | 24,733 |
| 2020-01-02 | Hoppenot Herve | Chairman / CEO |
Other disposed transaction
F
|
Common Stock | 28,345 | $85.97 | $2,436,820 | 183,851 |
| 2019-12-31 | FOUSE JACQUALYN A | Dir |
Equity grant / award
A
|
Common Stock | 218 | $87.32 | $19,036 | 3,049 |
| 2019-12-17 | HARRIGAN EDMUND | Dir |
Equity grant / award
A · derivative
|
Non-Qualified Stock Option | 4,360 | $0.00 | $0 | 4,360 |
| 2019-12-17 | HARRIGAN EDMUND | Dir |
Equity grant / award
A
|
Common Stock | 462 | $0.00 | $0 | 462 |
| 2019-12-16 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,500 | $0.00 | $0 | 6,639 |
| 2019-12-16 | SWAIN PAULA J | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 2,500 | $91.61 | $229,025 | 41,612 |
| 2019-12-16 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 2,500 | $64.55 | $161,375 | 44,112 |
| 2019-12-12 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 77 | $0.00 | $0 | 4,587 |
| 2019-12-12 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 77 | $65.36 | $5,033 | 18,833 |
| 2019-12-10 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Other disposed transaction
F
|
Common Stock | 533 | $95.72 | $51,019 | 13,106 |
| 2019-12-02 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 16,835 | $0.00 | $0 | 17,542 |
| 2019-12-02 | Wenqing Yao | EVP, Head of Discovery Chem |
Open-market sell
S
|
Common Stock | 16,835 | $95.00 | $1,599,325 | 95,308 |
| 2019-12-02 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M
|
Common Stock | 16,835 | $18.32 | $308,417 | 112,143 |
| 2019-11-29 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 3,165 | $0.00 | $0 | 34,377 |
| 2019-11-29 | Wenqing Yao | EVP, Head of Discovery Chem |
Open-market sell
S
|
Common Stock | 3,165 | $95.00 | $300,675 | 95,308 |
| 2019-11-29 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M
|
Common Stock | 3,165 | $18.32 | $57,983 | 98,473 |
| 2019-11-25 | Flannelly Barry P | EVP & General Manager US |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 1,720 | $0.00 | $0 | 0 |
| 2019-11-25 | Flannelly Barry P | EVP & General Manager US |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 422 | $0.00 | $0 | 20,000 |
| 2019-11-25 | Flannelly Barry P | EVP & General Manager US |
Open-market sell
S
|
Common Stock | 1,720 | $90.00 | $154,800 | 16,979 |
| 2019-11-25 | Flannelly Barry P | EVP & General Manager US |
Exercise / conversion
M
|
Common Stock | 1,720 | $48.44 | $83,317 | 18,699 |
| 2019-11-25 | Flannelly Barry P | EVP & General Manager US |
Open-market sell
S
|
Common Stock | 422 | $90.00 | $37,980 | 16,979 |
| 2019-11-25 | Flannelly Barry P | EVP & General Manager US |
Exercise / conversion
M
|
Common Stock | 422 | $48.44 | $20,442 | 17,401 |
| 2019-11-15 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,500 | $0.00 | $0 | 9,139 |
| 2019-11-15 | SWAIN PAULA J | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 2,500 | $86.46 | $216,150 | 41,612 |
| 2019-11-15 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 2,500 | $64.55 | $161,375 | 44,112 |
| 2019-11-13 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 76 | $0.00 | $0 | 4,664 |
| 2019-11-13 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 76 | $65.36 | $4,967 | 18,756 |
| 2019-11-08 | DIXON WENDY L | Dir |
Exercise / conversion
M · derivative
|
Non Qualfied Stock Option (right to buy) | 18,334 | $0.00 | $0 | 0 |
| 2019-11-08 | DIXON WENDY L | Dir |
Exercise / conversion
M · derivative
|
Non Qualfied Stock Option (right to buy) | 22,884 | $0.00 | $0 | 0 |
| 2019-11-08 | DIXON WENDY L | Dir |
Open-market sell
S
|
Common Stock | 18,334 | $83.87 | $1,537,673 | 12,340 |
| 2019-11-08 | DIXON WENDY L | Dir |
Exercise / conversion
M
|
Common Stock | 18,334 | $12.46 | $228,442 | 30,674 |
| 2019-11-08 | DIXON WENDY L | Dir |
Open-market sell
S
|
Common Stock | 22,884 | $83.87 | $1,919,281 | 12,340 |
| 2019-11-08 | DIXON WENDY L | Dir |
Exercise / conversion
M
|
Common Stock | 22,884 | $12.46 | $285,135 | 35,224 |
| 2019-11-07 | DIXON WENDY L | Dir |
Exercise / conversion
M · derivative
|
Non Qualfied Stock Option (right to buy) | 1,540 | $0.00 | $0 | 22,884 |
| 2019-11-07 | DIXON WENDY L | Dir |
Open-market sell
S
|
Common Stock | 1,540 | $83.60 | $128,744 | 12,340 |
| 2019-11-07 | DIXON WENDY L | Dir |
Exercise / conversion
M
|
Common Stock | 1,540 | $12.46 | $19,188 | 13,880 |
| 2019-11-06 | DIXON WENDY L | Dir |
Exercise / conversion
M · derivative
|
Non Qualfied Stock Option (right to buy) | 10,576 | $0.00 | $0 | 24,424 |
| 2019-11-06 | DIXON WENDY L | Dir |
Open-market sell
S
|
Common Stock | 10,576 | $84.16 | $890,076 | 12,340 |
| 2019-11-06 | DIXON WENDY L | Dir |
Exercise / conversion
M
|
Common Stock | 10,576 | $12.46 | $131,777 | 22,916 |
| 2019-11-01 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 7,960 | $0.00 | $0 | 52,542 |
| 2019-11-01 | Wenqing Yao | EVP, Head of Discovery Chem |
Open-market sell
S
|
Common Stock | 7,960 | $85.00 | $676,600 | 95,308 |
| 2019-11-01 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M
|
Common Stock | 7,960 | $18.32 | $145,827 | 103,268 |
| 2019-10-30 | Wenqing Yao | EVP, Head of Discovery Chem |
Equity grant / award
A
|
Common Stock | 50,000 | $0.00 | $0 | 95,308 |
| 2019-10-30 | Stein Steven H | EVP & Chief Medical Officer |
Equity grant / award
A
|
Common Stock | 50,000 | $0.00 | $0 | 66,473 |
| 2019-10-29 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,040 | $0.00 | $0 | 60,502 |
| 2019-10-29 | Wenqing Yao | EVP, Head of Discovery Chem |
Open-market sell
S
|
Common Stock | 2,040 | $85.00 | $173,400 | 45,308 |
| 2019-10-29 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M
|
Common Stock | 2,040 | $18.32 | $37,373 | 47,348 |
| 2019-10-22 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,500 | $0.00 | $0 | 11,639 |
| 2019-10-22 | SWAIN PAULA J | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 2,500 | $80.00 | $200,000 | 41,612 |
| 2019-10-22 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 2,500 | $64.55 | $161,375 | 44,112 |
| 2019-10-10 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 77 | $0.00 | $0 | 4,740 |
| 2019-10-10 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 77 | $65.36 | $5,033 | 18,680 |
| 2019-09-30 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A
|
Common Stock | 364 | $74.23 | $27,020 | 29,291,207 |
| 2019-09-18 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,500 | $0.00 | $0 | 14,139 |
| 2019-09-18 | SWAIN PAULA J | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 2,500 | $80.00 | $200,000 | 41,612 |
| 2019-09-18 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 2,500 | $64.55 | $161,375 | 44,112 |
| 2019-09-17 | Flannelly Barry P | EVP & General Manager US |
Open-market sell
S
|
Common Stock | 2,491 | $77.71 | $193,576 | 16,757 |
| 2019-09-09 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 76 | $0.00 | $0 | 4,817 |
| 2019-09-09 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 76 | $65.36 | $4,967 | 18,603 |
| 2019-08-15 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,500 | $0.00 | $0 | 16,639 |
| 2019-08-15 | SWAIN PAULA J | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 2,500 | $80.96 | $202,400 | 41,612 |
| 2019-08-15 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 2,500 | $64.55 | $161,375 | 44,112 |
| 2019-08-09 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 1,223 | $0.00 | $0 | 4,893 |
| 2019-08-09 | Pasquale Maria E | EVP & General Counsel |
Exercise / conversion
M
|
Common Stock | 1,223 | $65.36 | $79,935 | 18,527 |
| 2019-08-06 | FRIEDMAN PAUL A | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 77,934 | $0.00 | $0 | 0 |
| 2019-08-06 | FRIEDMAN PAUL A | Dir |
Open-market sell
S
|
Common Stock | 77,934 | $82.20 | $6,406,175 | 255,531 |
| 2019-08-06 | FRIEDMAN PAUL A | Dir |
Exercise / conversion
M
|
Common Stock | 77,934 | $18.32 | $1,427,751 | 333,465 |
| 2019-08-02 | BIENAIME JEAN JACQUES | Dir |
Open-market sell
S
|
Common Stock | 377 | $84.73 | $31,943 | 7,055 |
| 2019-08-02 | FRIEDMAN PAUL A | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 22,066 | $0.00 | $0 | 77,934 |
| 2019-08-02 | FRIEDMAN PAUL A | Dir |
Open-market sell
S
|
Common Stock | 22,066 | $84.41 | $1,862,591 | 255,531 |
| 2019-08-02 | FRIEDMAN PAUL A | Dir |
Exercise / conversion
M
|
Common Stock | 22,066 | $18.32 | $404,249 | 277,597 |
| 2019-08-01 | BIENAIME JEAN JACQUES | Dir |
Open-market sell
S
|
Common Stock | 1,347 | $85.16 | $114,711 | 7,432 |
| 2019-07-17 | Flannelly Barry P | EVP & General Manager US |
Open-market sell
S
|
Common Stock | 959 | $79.91 | $76,634 | 19,248 |
| 2019-07-15 | Hoppenot Herve | Chairman / CEO |
Other disposed transaction
F
|
Common Stock | 2,400 | $81.39 | $195,336 | 212,196 |
| 2019-07-05 | Wenqing Yao | EVP, Head of Discovery Chem |
Other disposed transaction
F
|
Common Stock | 404 | $85.28 | $34,453 | 45,947 |
| 2019-07-02 | Hoppenot Herve | Chairman / CEO |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 96,327 | $0.00 | $0 | 96,327 |
| 2019-07-02 | Hoppenot Herve | Chairman / CEO |
Other disposed transaction
F
|
Common Stock | 2,410 | $85.01 | $204,874 | 216,148 |
| 2019-07-02 | Hoppenot Herve | Chairman / CEO |
Equity grant / award
A
|
Common Stock | 39,648 | $0.00 | $0 | 218,558 |
| 2019-06-28 | FOUSE JACQUALYN A | Dir |
Equity grant / award
A
|
Common Stock | 203 | $84.96 | $17,247 | 2,580 |
| 2019-06-24 | Stein Steven H | EVP & Chief Medical Officer |
Open-market sell
S
|
Common Stock | 8,357 | $87.96 | $735,082 | 10,805 |
| 2019-06-17 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 2,500 | $0.00 | $0 | 21,639 |
| 2019-06-17 | SWAIN PAULA J | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 2,500 | $80.00 | $200,000 | 36,513 |
| 2019-06-17 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 2,500 | $64.55 | $161,375 | 39,013 |
| 2019-06-06 | BAKER BROS. ADVISORS LP | Dir |
Other acquired transaction
J
|
Common Stock | 220,141 | $0.00 | $0 | 281,190 |
| 2019-06-06 | BAKER BROS. ADVISORS LP | Dir |
Other disposed transaction
J
|
Common Stock | 692,706 | $0.00 | $0 | 0 |
| 2019-06-06 | BAKER BROS. ADVISORS LP | Dir |
Other disposed transaction
J
|
Common Stock | 1,603,238 | $0.00 | $0 | 2,826,766 |
| 2019-05-09 | Iyengar Vijay K | EVP GPS, BD, & Licensing |
Other disposed transaction
F
|
Common Stock | 1,434 | $82.02 | $117,617 | 12,468 |
| 2019-04-26 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A · derivative
|
Non-Qualified Stock Options (right to buy) | 12,472 | $0.00 | $0 | 12,472 |
| 2019-04-26 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A
|
Common Stock | 1,520 | $0.00 | $0 | 812,602 |
| 2019-04-09 | Pasquale Maria E | EVP & General Counsel |
Other disposed transaction
F
|
Common Stock | 517 | $82.73 | $42,771 | 11,013 |
| 2019-04-01 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 8,218 | $0.00 | $0 | 0 |
| 2019-04-01 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 1,782 | $0.00 | $0 | 0 |
| 2019-04-01 | SWAIN PAULA J | EVP, Human Resources |
Open-market sell
S
|
Commons Stock | 8,218 | $87.01 | $715,048 | 36,513 |
| 2019-04-01 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M
|
Commons Stock | 8,218 | $18.32 | $150,554 | 44,731 |
| 2019-04-01 | SWAIN PAULA J | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 1,782 | $87.01 | $155,052 | 36,513 |
| 2019-04-01 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 1,782 | $18.32 | $32,646 | 38,295 |
| 2019-03-29 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A
|
Common Stock | 220 | $86.01 | $18,922 | 811,082 |
| 2019-03-01 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 10,000 | $0.00 | $0 | 1,782 |
| 2019-03-01 | SWAIN PAULA J | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 10,000 | $86.68 | $866,800 | 36,513 |
| 2019-03-01 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 10,000 | $18.32 | $183,200 | 46,513 |
| 2019-02-26 | BAKER BROS. ADVISORS LP | Dir |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Options (right to buy) | 20,000 | $0.00 | $0 | 0 |
| 2019-02-26 | BAKER BROS. ADVISORS LP | Dir |
Exercise / conversion
M
|
Common Stock | 20,000 | $2.80 | $56,000 | 29,288,793 |
| 2019-02-14 | Hoppenot Herve | Chairman / CEO |
Equity grant / award
A
|
Common Stock | 20,971 | $0.00 | $0 | 158,503 |
| 2019-02-11 | Stamoulis Christiana | EVP & Chief Financial Officer |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 72,809 | $0.00 | $0 | 72,809 |
| 2019-02-11 | Stamoulis Christiana | EVP & Chief Financial Officer |
Equity grant / award
A
|
Common Stock | 10,285 | $80.21 | $824,960 | 10,285 |
| 2019-02-01 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 10,000 | $0.00 | $0 | 11,782 |
| 2019-02-01 | SWAIN PAULA J | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 10,000 | $81.19 | $811,900 | 31,124 |
| 2019-02-01 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 10,000 | $18.32 | $183,200 | 41,124 |
| 2019-01-28 | Flannelly Barry P | EVP & General Manager US |
Open-market sell
S
|
Common Stock | 1,000 | $80.00 | $80,000 | 8,944 |
| 2019-01-17 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 15,354 | $0.00 | $0 | 0 |
| 2019-01-17 | Wenqing Yao | EVP, Head of Discovery Chem |
Open-market sell
S
|
Common Stock | 15,354 | $77.61 | $1,191,624 | 34,409 |
| 2019-01-17 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M
|
Common Stock | 15,354 | $17.79 | $273,148 | 49,763 |
| 2019-01-15 | Trower Paul | Principal Accounting Officer |
Exercise / conversion
M · derivative
|
Incentive Stock Option (right to buy) | 5,813 | $0.00 | $0 | 0 |
| 2019-01-15 | Trower Paul | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 5,813 | $75.00 | $435,975 | 13,900 |
| 2019-01-15 | Trower Paul | Principal Accounting Officer |
Exercise / conversion
M
|
Common Stock | 5,813 | $17.79 | $103,413 | 19,713 |
| 2019-01-08 | Flannelly Barry P | EVP & General Manager US |
Open-market sell
S
|
Common Stock | 1,714 | $75.56 | $129,510 | 9,944 |
| 2019-01-07 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 10,000 | $0.00 | $0 | 15,354 |
| 2019-01-07 | Wenqing Yao | EVP, Head of Discovery Chem |
Other disposed transaction
F
|
Common Stock | 808 | $74.21 | $59,962 | 34,409 |
| 2019-01-07 | Wenqing Yao | EVP, Head of Discovery Chem |
Open-market sell
S
|
Common Stock | 10,000 | $75.00 | $750,000 | 35,217 |
| 2019-01-07 | Wenqing Yao | EVP, Head of Discovery Chem |
Exercise / conversion
M
|
Common Stock | 10,000 | $17.79 | $177,900 | 45,217 |
| 2019-01-04 | Wenqing Yao | EVP, Head of Discovery Chem |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 22,772 | $0.00 | $0 | 22,772 |
| 2019-01-02 | Hoppenot Herve | Chairman / CEO |
Other disposed transaction
F
|
Common Stock | 27,630 | $63.56 | $1,756,163 | 157,136 |
| 2018-12-31 | FOUSE JACQUALYN A | Dir |
Equity grant / award
A
|
Common Stock | 196 | $63.59 | $12,464 | 712 |
| 2018-12-10 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Equity grant / award
A · derivative
|
Employee Stock Option (right to buy) | 48,403 | $0.00 | $0 | 48,403 |
| 2018-12-10 | Dhanak Dashyant | EVP & Chief Scientific Officer |
Equity grant / award
A
|
Common Stock | 6,878 | $0.00 | $0 | 6,878 |
| 2018-11-08 | BIENAIME JEAN JACQUES | Dir |
Open-market buy
P
|
Common Stock | 500 | $68.91 | $34,455 | 6,668 |
| 2018-10-03 | Trower Paul | Principal Accounting Officer |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 10,000 | $0.00 | $0 | 9,187 |
| 2018-10-03 | Trower Paul | Principal Accounting Officer |
Open-market sell
S
|
Common Stock | 10,000 | $70.00 | $700,000 | 14,172 |
| 2018-10-03 | Trower Paul | Principal Accounting Officer |
Exercise / conversion
M
|
Common Stock | 10,000 | $17.79 | $177,900 | 24,172 |
| 2018-09-28 | BAKER BROS. ADVISORS LP | Dir |
Equity grant / award
A
|
Common Stock | 275 | $69.08 | $18,997 | 810,564 |
| 2018-09-04 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 10,000 | $0.00 | $0 | 61,782 |
| 2018-09-04 | SWAIN PAULA J | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 10,000 | $73.21 | $732,100 | 32,324 |
| 2018-09-04 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 10,000 | $18.32 | $183,200 | 42,324 |
| 2018-08-21 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M · derivative
|
Non-Qualified Stock Option (right to buy) | 10,000 | $0.00 | $0 | 71,782 |
| 2018-08-21 | SWAIN PAULA J | EVP, Human Resources |
Open-market sell
S
|
Common Stock | 10,000 | $70.00 | $700,000 | 32,324 |
| 2018-08-21 | SWAIN PAULA J | EVP, Human Resources |
Exercise / conversion
M
|
Common Stock | 10,000 | $18.32 | $183,200 | 42,324 |